var title_f43_18_44320="Rickets bow-legs";
var content_f43_18_44320=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F54617&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F54617&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bowing of the legs in a child with rickets",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 290px; height: 544px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nutritional rickets (vitamin D deficiency) in a three-year-old boy. Note the severe bowing of the lower extremities and the wider wrists and ankles.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Becker KL, Bilezikian JP, Brenner WJ, et al. Principles and Practice of Endocrinology and Metabolism, 3rd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44320=[""].join("\n");
var outline_f43_18_44320=null;
var title_f43_18_44321="Elbow tendinopathy (tennis and golf elbow)";
var content_f43_18_44321=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Elbow tendinopathy (tennis and golf elbow) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?43/18/44321/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44321/contributors\" id=\"au1772\">",
"       Neeru Jayanthi, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?43/18/44321/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44321/contributors\" id=\"se7143\">",
"       Karl B Fields, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?43/18/44321/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44321/contributors\" id=\"de97\">",
"       Jonathan Grayzel, MD, FAAEM",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?43/18/44321?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     Tendons are tough bands of tissue that connect muscles to bones. There are several types of tendon problems (called tendinopathies):",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Repetitive activities and sudden trauma can injure tendons and lead to inflammation, pain, and difficulty using the joint. This is called",
"       <strong>",
"        tendinitis",
"       </strong>",
"       .",
"      </li>",
"      <li>",
"       As people age, tendons can break down (degenerate) or even tear; this is called",
"       <strong>",
"        tendinosis",
"       </strong>",
"       . Symptoms of tendinosis usually last more than a few weeks.",
"      </li>",
"      <li>",
"       Less commonly, tendon problems can be caused by other conditions, including rheumatic diseases.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Tendinopathies are common problems. The risk of having a tendinopathy increases with age and is greater in people who routinely perform activities that require repetitive movement that increases stress on susceptible tendons.",
"    </p>",
"    <p>",
"     Treatment of tendinopathy focuses on resting and protecting the injured tendon so that it can heal, inflammation can resolve, and muscle strength can improve. In most people, tendinopathy resolves with little or no treatment.",
"    </p>",
"    <p>",
"     Tendinopathy can affect many different tendons in the body. Separate articles discuss other types of tendon problems. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/36/25153?source=see_link\">",
"      \"Patient information: Biceps tendinitis or tendinopathy (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/49/24341?source=see_link\">",
"      \"Patient information: Rotator cuff tendinitis and tear (Beyond the Basics)\"",
"     </a>",
"     .) More detailed information about elbow tendinitis is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/20/1354?source=see_link\">",
"      \"Epicondylitis (tennis and golf elbow)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHAT IS ELBOW TENDINOPATHY?",
"     </span>",
"    </p>",
"    <p>",
"     Tendinopathy (tendinitis or tendinosis) is the most common condition affecting the elbow.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       It is called \"tennis elbow\" or lateral epicondylitis when there is an injury to the outer elbow tendon",
"      </li>",
"      <li>",
"       It is called \"golfer's elbow\" or medial epicondylitis when there is an injury to the inner elbow tendon",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     However, elbow tendinopathy can be caused by sports other than golf and tennis, as well as work-related activities that involve heavy use of the wrist and forearm muscles.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      ELBOW TENDINOPATHY SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Elbow tendinopathy most often affects the dominant arm (ie, the right arm in people who are right-handed, etc.). Symptoms include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Pain in the elbow that spreads into the upper arm or down to the forearm",
"      </li>",
"      <li>",
"       Weakness of the forearm",
"      </li>",
"      <li>",
"       Pain can begin suddenly or can develop gradually over time",
"      </li>",
"      <li>",
"       You might have a harder time with activities that require arm strength, including sports that require you to hit backhand or throw a ball",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      ELBOW TENDINOPATHY DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Elbow tendinopathy is usually diagnosed based on an exam and your description of pain.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      ELBOW TENDINOPATHY TREATMENT",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Pain relief",
"     </span>",
"     &nbsp;&mdash;&nbsp;If needed, you can take a pain medicine, such as acetaminophen (sold as Tylenol&reg; and other brands), ibuprofen (sold as Advil&reg;, Motrin&reg;), or naproxen (sold as Aleve&reg;). (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/13/2262?source=see_link\">",
"      \"Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)\"",
"     </a>",
"     .) You should not take more than 4000 mg of acetaminophen per day. If you have liver disease or drink alcohol regularly, you should speak with your doctor or nurse before taking acetaminophen.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Arm brace",
"     </span>",
"     &nbsp;&mdash;&nbsp;A tennis elbow brace or strap applies pressure to the muscles of the forearm, reducing pressure on the injured tendon in the elbow. You can use the brace or strap while working or playing sports. Apply the brace so that the cushion is resting on your forearm muscles, about 3 to 4 inches (10 cm) from the tip of the elbow bone. You may need to wear the brace for up to six weeks. Avoid wearing a wrist splint (which prevents your forearm from moving).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Flexibility exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;Flexibility exercises can help to improve your arm's strength and ability to move.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Tennis elbow",
"     </span>",
"     &nbsp;&mdash;&nbsp;While standing or sitting upright, hold your injured arm straight out in front of you and point your fingers down toward the ground. With the hand of the uninjured arm, grasp the hand of the injured arm, thumb pressing on the palm, and try to bend the wrist further (",
"     <a class=\"graphic graphic_picture graphicRef65485 \" href=\"mobipreview.htm?29/38/30319\">",
"      picture 1",
"     </a>",
"     ). Hold for 30 seconds; repeat three times. Perform this stretch daily.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h3\">",
"      Golfer's elbow",
"     </span>",
"     &nbsp;&mdash;&nbsp;Stand at arm's length away from a wall, with the affected arm closest to the wall. Place the palm against the wall with the fingers pointing down. Apply gentle pressure to the hand. Hold for 30 seconds; repeat three times. Perform this stretch daily.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Strengthening exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;A special type of strengthening exercise, known as &ldquo;eccentric strengthening,&rdquo; is the most effective way to treat elbow tendinopathy. Patients can start these exercises once their flexibility has improved and they have little or no pain when performing a strengthening exercise. Eccentric strengthening involves working the affected wrist extensor tendon and muscle while they are lengthening. Patients can use a weight, elastic band, or a specially designed rubber bar to do these exercises, and they may be done under supervision or independently. Eccentric training was superior when compared to other types of strengthening [",
"     <a class=\"abstract\" href=\"mobipreview.htm?43/18/44321/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Tennis elbow",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with tennis elbow should perform eccentric",
"     <strong>",
"      extension",
"     </strong>",
"     exercises (",
"     <a class=\"graphic graphic_picture graphicRef81949 \" href=\"mobipreview.htm?37/23/38270\">",
"      picture 2",
"     </a>",
"     ). You should expect to feel some mild discomfort with these exercises. If the pain becomes sharp or is more than moderate, stop the exercise and rest for two to three days. Restart with fewer repetitions.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Golfer's elbow",
"     </span>",
"     &nbsp;&mdash;&nbsp;Golfer's elbow is treated with eccentric",
"     <strong>",
"      flexion",
"     </strong>",
"     exercises. You should expect to feel some mild discomfort with these exercises. If the pain becomes sharp or is more than moderate, stop the exercise and rest for two to three days. Restart with a lighter weight or fewer repetitions.",
"    </p>",
"    <p>",
"     Sit with your arm supported (on a table) at shoulder height. The back of your hand should face the floor, and your hand should hang off the table. Start with your elbow bent, which is less painful, then progress to keeping your elbow straight. Hold a 1 pound weight in the hand. Using the unaffected hand, lift the hand with the weight toward the body (keep the arm flat against the table).",
"    </p>",
"    <p>",
"     Move the unaffected hand away, and slowly allow the affected hand (with the weight) to drop. Repeat 15 times, then rest one minute. Repeat two more times. Perform five times per week.",
"    </p>",
"    <p>",
"     After one week, try to lift the hand with the weight without assistance. Increase the weight by 1 to 2 pounds per week. Do not increase the weight unless you can complete 15 lifts.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Kinetic chain",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you play a sport that requires arm strength (such as tennis or golf), hold a 1 to 2 pound weight in your hand and reproduce the wrist and elbow motions of your sport. At the same time, brace your lower body and core (back and abdomen) muscles.",
"    </p>",
"    <p>",
"     Then, replace the weight with a golf club or tennis racket and practice your swing (without the ball). If you do the exercises incorrectly, you may feel more pain. If you have pain with strengthening exercises, consider seeing a rehabilitation specialist, such as a physical therapist or athletic trainer, to help supervise your recovery.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      When will I feel better?",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people respond well to treatment. You might have some pain during work or sports for up to 6 to 12 weeks. Some people will need formal rehabilitation with a physical therapist.",
"    </p>",
"    <p>",
"     If your pain persists, an injection into the painful tendon might help to relieve pain. In addition, there are many new treatments being developed to promote tendon healing, such as using blood products, shock wave therapy, acupuncture, and nitroglycerin patches. Surgery is not usually needed unless symptoms have not improved after six or more months of treatment. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/20/1354?source=see_link\">",
"      \"Epicondylitis (tennis and golf elbow)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      ELBOW TENDINOPATHY PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     A healthy elbow requires a healthy shoulder and wrist joint and strong muscles around the scapula (shoulder blades) and arms to decrease the load on the smaller forearm muscles.",
"    </p>",
"    <p>",
"     To prevent overuse and strain in the elbow and forearm:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Take frequent breaks from activities that require extensive",
"       <span class=\"nowrap\">",
"        hand/wrist",
"       </span>",
"       motions.",
"      </li>",
"      <li>",
"       Reduce or avoid lifting objects with the arm extended.",
"      </li>",
"      <li>",
"       Reduce repetitive gripping and grasping with the hand and wrist. Decrease the overall tension of gripping.",
"      </li>",
"      <li>",
"       Avoid the extremes of bending and full extension.",
"      </li>",
"      <li>",
"       Work or weight-train with the elbow in a partially bent position. Use wrist supports when weight-training.",
"      </li>",
"      <li>",
"       When using tools, increase the gripping surface by wearing gloves or adding padding. Use a hammer with extra padding to reduce tension and impact. Hold heavy tools with two hands.",
"      </li>",
"      <li>",
"       Use a two-handed backhand in tennis. When hitting a tennis stroke, use your entire lower body, hip, pelvis, and back, and use less of your elbow. Using the proper technique in tennis can help reduce symptoms. Reevaluate the size of your grip, string tension, type of string, new strokes, and new grips for new strokes, which can all contribute to problems.",
"       <br/>",
"       <br/>",
"       Some suggest lowering string tension, finding the heaviest racket that does not affect your swing speed, finding the largest grip that is comfortable, and using softer strings.",
"      </li>",
"      <li>",
"       Apply grip tape or an oversized grip on golf clubs.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1785007003\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18218598\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/23/3443?source=see_link\">",
"      Patient information: Bursitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/32/2563?source=see_link\">",
"      Patient information: Biceps tendinopathy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/47/38642?source=see_link\">",
"      Patient information: Elbow tendinopathy (tennis and golf elbow) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18218635\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/36/25153?source=see_link\">",
"      Patient information: Biceps tendinitis or tendinopathy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/49/24341?source=see_link\">",
"      Patient information: Rotator cuff tendinitis and tear (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/13/2262?source=see_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/25/22937?source=see_link\">",
"      Elbow injuries in the young athlete",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/20/1354?source=see_link\">",
"      Epicondylitis (tennis and golf elbow)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/40/14983?source=see_link\">",
"      Evaluation of elbow pain in adults",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Orthopaedic Surgeons",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://orthoinfo.aaos.org/main.cfm\">",
"      file://orthoinfo.aaos.org/main.cfm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?43/18/44321/abstract/2-4\">",
"      2-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 5, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?43/18/44321?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44321/abstract/1\">",
"      Tyler TF, Thomas GC, Nicholas SJ, McHugh MP. Addition of isolated wrist extensor eccentric exercise to standard treatment for chronic lateral epicondylosis: a prospective randomized trial. J Shoulder Elbow Surg 2010; 19:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44321/abstract/2\">",
"      De Smedt T, de Jong A, Van Leemput W, et al. Lateral epicondylitis in tennis: update on aetiology, biomechanics and treatment. Br J Sports Med 2007; 41:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44321/abstract/3\">",
"      Bisset L, Beller E, Jull G, et al. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ 2006; 333:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44321/abstract/4\">",
"      Smidt N, Assendelft WJ, Arola H, et al. Effectiveness of physiotherapy for lateral epicondylitis: a systematic review. Ann Med 2003; 35:51.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f43_18_44321=[""].join("\n");
var outline_f43_18_44321=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHAT IS ELBOW TENDINOPATHY?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           ELBOW TENDINOPATHY SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           ELBOW TENDINOPATHY DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           ELBOW TENDINOPATHY TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           ELBOW TENDINOPATHY PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/38/30319\" title=\"picture 1\">",
"           Forearm extensor stretch PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/23/38270\" title=\"picture 2\">",
"           Epicond eccentric rehab PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f43_18_44322="Vitamin B2 (riboflavin): Pediatric drug information";
var content_f43_18_44322=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Vitamin B2 (riboflavin): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?17/15/17651?source=see_link\">",
"    see \"Vitamin B2 (riboflavin): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?26/34/27171?source=see_link\">",
"    see \"Vitamin B2 (riboflavin): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F218108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ribo-100 [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1061855\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Nutritional Supplement",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Vitamin, Water Soluble",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11444953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Adequate intake: 0.3 mg/day (0.04 mg/kg/day)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1061847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?17/15/17651?source=see_link\">",
"      see \"Vitamin B2 (riboflavin): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Riboflavin deficiency:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 3-10 mg/day in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 5-30 mg/day in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adequate intake: Infants:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 to &lt;6 months: 0.3 mg (0.04 mg/kg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     6-12 months: 0.4 mg (0.04 mg/kg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Recommended daily allowance (RDA): Children and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-3 years: 0.5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-8 years: 0.6 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     9-13 years: 0.9 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     14-18 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Male: 1.3 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Female: 1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     19-70 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Male: 1.3 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Female: 1.1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Microcytic anemia associated with glutathione reductase deficiency: Adults: 10 mg daily for 10 days",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F218095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 25 mg, 50 mg, 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ribo-100: 100 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F218081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1061858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer with food",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1061851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Protect from light",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1061857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention of riboflavin deficiency and treatment of ariboflavinosis; microcytic anemia associated with glutathione reductase deficiency",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F218138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Riboflavin may be confused with ribavirin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F218137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Genitourinary: Discoloration of urine (yellow-orange)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1061861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to riboflavin or any component",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299998\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F218089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1061862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food increases the extent of GI absorption",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13872727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Water-soluble vitamins cross the placenta. Riboflavin requirements may be increased in pregnant women compared to nonpregnant women (IOM, 1998).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1061854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC and reticulocyte counts (if anemic when treating deficiency)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1061846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Converted to coenzymes which act as hydrogen-carrier molecules, which are necessary for normal tissue respiration; also needed for activation of pyridoxine and conversion of tryptophan to niacin",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1061860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Readily via GI tract; GI absorption is decreased in patients with hepatitis, cirrhosis, or biliary obstruction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Metabolic fate unknown",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, biologic: 66-84 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 9% eliminated unchanged in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1061853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?26/34/27171?source=see_link\">",
"      see \"Vitamin B2 (riboflavin): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Large doses may cause bright yellow urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12765 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-197.136.42.3-3A022BFF98-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44322=[""].join("\n");
var outline_f43_18_44322=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218108\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061855\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11444953\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061847\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218095\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218081\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061858\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061851\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061857\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218138\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218137\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061861\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299998\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218089\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061862\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13872727\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061854\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061846\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061860\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061853\">",
"      Patient Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12765\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12765|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?17/15/17651?source=related_link\">",
"      Vitamin B2 (riboflavin): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?26/34/27171?source=related_link\">",
"      Vitamin B2 (riboflavin): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_18_44323="Multiple nerve plexuses B";
var content_f43_18_44323=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F67835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F67835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Multiple nerve plexuses are found in the lower airways",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 211px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    a) Luminal view of the airway mucosa of a 39-year old nonsmoker reveals that nerves, almost certainly vagal afferent nerves, project to the airway mucosa and epithelium. Many of these epithelial nerve fibers have varicosities (arrowhead), suggesting they may be able to release neurotransmitters locally in an axon reflex response. b) Cross-sectional confocal image of the photomicrograph in panel a reveals that axons of these sensory nerves occupy a plexus immediately below the luminal surface. c) Airway smooth muscle (stained in red with antisera to a-actin) as well as glands and bronchial vasculature (neither visible in this photomicrograph) are innervated by postganglionic autonomic nerve fibers (stained green with antisera to PGP 9.5).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Figures a) and b) reproduced with permission from: Reproduced with permission from: Sparrow MP, Weichselbaum M, McCray PB. Development of the innervation and airway smooth muscle in human fetal lung. Am J Respir Cell Mol Biol. 1999; 20:550. Figure c) reproduced from Sparrow MP, Weichselbaum M, McCray PB. Development of the innervation and airway smooth muscle in human fetal lung. Am J Respir Cell Mol Biol. 1999; 20:550.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44323=[""].join("\n");
var outline_f43_18_44323=null;
var title_f43_18_44324="Recombinant human factor VIIa: Pediatric drug information";
var content_f43_18_44324=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Recombinant human factor VIIa: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?29/42/30373?source=see_link\">",
"    see \"Recombinant human factor VIIa: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?10/40/10884?source=see_link\">",
"    see \"Recombinant human factor VIIa: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F10053630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F169443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      NovoSeven&reg; RT",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F169444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Niastase&reg;;",
"     </li>",
"     <li>",
"      Niastase&reg; RT",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1058582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihemophilic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1058575\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?29/42/30373?source=see_link\">",
"      see \"Recombinant human factor VIIa: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Children and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hemophilia A or B with inhibitors:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Bleeding episodes:",
"     </i>",
"     90 mcg/kg every 2 hours until hemostasis is achieved or until the treatment is judged ineffective. The dose and interval may be adjusted based upon the severity of bleeding and the degree of hemostasis achieved. Doses between 35-120 mcg/kg have been used successfully in clinical trials. The dose, interval, and duration of therapy may be adjusted based on severity of bleeding and the degree of hemostasis achieved. For patients treated for joint or muscle bleeds, a decision on the outcome of treatment was reached within 8 doses in the majority of patients, although more doses were required for severe bleeds; adverse effects were reported most commonly in patients treated with 12 or more doses. For patients experiencing severe bleeds to maintain the hemostatic plug, dosing should be continued at 3- to 6-hour intervals; the duration of posthemostatic dosing should be minimized.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Surgical interventions:",
"     </i>",
"     90 mcg/kg immediately before surgery; repeat at 2-hour intervals for the duration of surgery. Continue every 2 hours for 48 hours, then every 2-6 hours until healed for minor surgery; continue every 2 hours for 5 days, then every 4 hours until healed for major surgery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Congenital factor VII deficiency: Bleeding episodes and surgical interventions: 15-30 mcg/kg every 4-6 hours until hemostasis is achieved. Doses as low as 10 mcg/kg have been effective; individualized dosing is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acquired hemophilia: 70-90 mcg/kg every 2-3 hours until hemostasis is achieved",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F169430\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     NovoSeven&reg; RT: 1 mg [contains polysorbate 80, sodium 0.4 mEq/mg rFVlla, sucrose 10 mg/vial; supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     NovoSeven&reg; RT: 2 mg [contains polysorbate 80, sodium 0.4 mEq/mg rFVlla, sucrose 20 mg/vial; supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     NovoSeven&reg; RT: 5 mg [contains polysorbate 80, sodium 0.4 mEq/mg rFVlla, sucrose 50 mg/vial; supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     NovoSeven&reg; RT: 8 mg [contains polysorbate 80, sodium 0.4 mEq/mg rFVlla, sucrose 80 mg/vial; supplied with diluent]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F169417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1058585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: I.V.: NovoSeven&reg; RT: Prior to reconstitution, bring to room temperature. Add recommended diluent along wall of vial; do not inject directly onto powder. Gently swirl until dissolved. Reconstitute each vial to a final concentration of 1 mg/mL using the provided histidine diluent as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     1 mg vial: 1.1 mL histidine diluent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     2 mg vial: 2.1 mL  histidine diluent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     5 mg vial: 5.2 mL histidine diluent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     8 mg vial: 8.1 mL histidine diluent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Administer as a slow bolus over 2-5 minutes.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1058578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     NovoSeven&reg; RT: Prior to reconstitution, store under refrigeration or between 2&deg;C to 25&deg;C (36&deg;F to 77&deg;F). Do not freeze. Protect from light. Reconstituted solutions may be stored at room temperature or under refrigeration but must be infused within 3 hours of reconstitution. Do not freeze reconstituted solutions. Do not store reconstituted solutions in syringes.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1058584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of bleeding episodes and prevention of bleeding in surgical interventions in patients with either hemophilia A or B when inhibitors to factor VIII or factor IX are present, acquired hemophilia, or congenital factor VII deficiency [FDA approved in pediatrics (age not specified) and adults]",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F169463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, edema, hyper-/hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Fever, headache, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, purpura, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Disseminated intravascular coagulation, fibrinolysis increased, plasma fibrinogen decreased, prothrombin decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthrosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Abnormal renal function",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pneumonia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Anaphylactic shock, angina, angioedema, antibody formation, arterial thrombosis, arterial thrombosis (limb), arthralgia, bowel infarction, cerebral artery occlusion, cerebral infarction and/or ischemia, consumptive coagulopathy, CVA, D-dimer elevation, deep vein thrombosis, fibrin degradation products increased, flushing, hepatic artery thrombosis, hypersensitivity, hypersensitivity reaction, injection site pain, intestinal infarction, I.V. site thrombosis, localized phlebitis, MI, myocardial ischemia, nausea, peripheral ischemia, portal vein thrombosis, pulmonary embolism, renal artery thrombosis, retinal artery embolism, retinal artery thrombosis, shock, thrombophlebitis, thrombosis, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1058589\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to factor VII or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1058574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hypersensitivity to mouse, hamster, bovine proteins.  Monitor PT and factor VII coagulant activity in factor VII deficient patients; if no response, may consider testing for antibody formation.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1058573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serious and sometimes fatal thrombotic events have been associated with the use of factor VIIa outside labeled indications",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Arterial and venous thrombotic and thromboembolic events, some fatal, following administration of factor VIIa have been reported during postmarketing surveillance. Thrombotic events have also been reported when used within labeled indications; thrombotic events may be increased in patients with disseminated intravascular coagulation (DIC), advanced atherosclerotic disease, sepsis, crush injury, or concomitant treatment with prothrombin complex concentrates. All patients receiving factor VIIa should be monitored for signs and symptoms of activation of the coagulation system or thrombosis. Efficacy with prolonged infusions and data evaluating long-term adverse effects are limited. Contains polysorbate 80 (Tween 80&reg;) which may cause allergic reactions in susceptible individuals. In premature neonates, thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported after receiving parenteral products containing polysorbate 80 (Alade, 1986;",
"     <i>",
"      MMWR",
"     </i>",
"     , 1984). Infusion of polysorbate 80-containing solutions through polyvinyl chloride tubing may cause DEHP to leach into the solution; in immature animals, exposure to DEHP may adversely affect the development of the male reproductive tract.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6220313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F169426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2181984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1058581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for evidence of hemostasis; although the prothrombin time/INR, aPTT, and factor VII clotting activity have no correlation with achieving clinical hemostasis, these parameters may be useful as adjunct tests to evaluate efficacy and guide dose or interval adjustments",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1058572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Recombinant factor VIIa, a vitamin K-dependent glycoprotein, promotes hemostasis by activating the extrinsic pathway of the coagulation cascade. It replaces deficient activated coagulation factor VII, which complexes with tissue factor and may activate coagulation factor X to Xa and factor IX to IXa. When complexed with other factors, coagulation factor Xa converts prothrombin to thrombin, a key step in the formation of a fibrin-platelet hemostatic plug.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1058587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 10-20 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: 6 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1058588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Children: 130 mL/kg; Adults: 103-105 mL/kg (range: 78-139 mL/kg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Elimination: Children: 1.32 hours; Adults: 2.3 hours (range: 1.7-2.7 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: 15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Clearance: Children: 67 mL/kg/hour; Adults: 30-36 mL/kg/hour (range: 27-49 mL/kg/hour)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1058580\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?10/40/10884?source=see_link\">",
"      see \"Recombinant human factor VIIa: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     This medication can only be administered I.V. Report swelling, pain, burning, or itching at infusion site. Report acute headache, visual changes, pain in joints or muscles, respiratory difficulty, chills, back pain, dizziness, nausea, or other unusual effects; inform healthcare provider if you are or intend to become pregnant.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1058590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Each mg factor VIIa contains 0.4 mEq sodium and 0.01 mEq calcium; &ldquo;off-label&rdquo; uses in limited patient populations have been reported (primarily adult patients) including reversal of anticoagulant over dose and reduction in bleeding associated with thrombocytopenia, trauma, hepatic dysfunction, and cardiac bypass surgery; further randomized, blinded clinical trials are needed to determine efficacy, dosage, and safety for these indications (Ghorashian, 2004; Tobias, 2004)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Alade SL, Brown RE, and Paquet A Jr, \"Polysorbate 80 and E-Ferol Toxicity,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1986, 77(4):593-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44324/abstract-text/3960626/pubmed\" id=\"3960626\" target=\"_blank\">",
"        3960626",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control (CDC), \"Unusual Syndrome With Fatalities Among Premature Infants: Association With a New Intravenous Vitamin E Product,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 1984, 33(14):198-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44324/abstract-text/6423951/pubmed\" id=\"6423951\" target=\"_blank\">",
"        6423951",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ghorashian S and Hunt BJ, &ldquo;'Off-License' Use of Recombinant Activated Factor VII,&rdquo;",
"      <i>",
"       Blood Rev",
"      </i>",
"      , 2004, 18(4):245-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44324/abstract-text/15501553/pubmed\" id=\"15501553\" target=\"_blank\">",
"        15501553",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goodnough LT, Lublin DM, Zhang L, et al, &ldquo;Transfusion Medicine Service Policies for Recombinant Factor VIIa Administration,&rdquo;",
"      <i>",
"       Transfusion",
"      </i>",
"      , 2004, 44(9):1325-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44324/abstract-text/15318856/pubmed\" id=\"15318856\" target=\"_blank\">",
"        15318856",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tobias JD, Simsic JM, Weinstein S, et al, &ldquo;Recombinant Factor VIIa to Control Excessive Bleeding Following Surgery for Congenital Heart Disease in Pediatric Patients,&rdquo;",
"      <i>",
"       J Intensive Care Med",
"      </i>",
"      , 2004, 19(5):270-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44324/abstract-text/15358945/pubmed\" id=\"15358945\" target=\"_blank\">",
"        15358945",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12916 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-202.43.93.2-77D3A94D3A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44324=[""].join("\n");
var outline_f43_18_44324=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10053630\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169443\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169444\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058582\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058575\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169430\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169417\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058585\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058578\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058584\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169463\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058589\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058574\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058573\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299309\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6220313\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169426\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2181984\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058581\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058572\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058587\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058588\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058580\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058590\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12916\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12916|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?29/42/30373?source=related_link\">",
"      Recombinant human factor VIIa: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?10/40/10884?source=related_link\">",
"      Recombinant human factor VIIa: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_18_44325="PA sling CT";
var content_f43_18_44325=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    CT scan demonstrates a pulmonary artery sling",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 394px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left pulmonary artery originates from the right pulmonary artery, courses anterior to the right bronchial tree, and ascends posterior to the trachea and anterior to the esophagus before crossing to the left side to enter the left hilar region.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44325=[""].join("\n");
var outline_f43_18_44325=null;
var title_f43_18_44326="Mammogram of early breast cancer";
var content_f43_18_44326=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F74338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F74338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Mammogram of early breast cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 489px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Digital spot compression views of the left breast demonstrate a small spiculated nodule in the lower inner quadrant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Pierre J Sasson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44326=[""].join("\n");
var outline_f43_18_44326=null;
var title_f43_18_44327="Rabeprazole: Drug information";
var content_f43_18_44327=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Rabeprazole: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/44/41668?source=see_link\">",
"    see \"Rabeprazole: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/44/43718?source=see_link\">",
"    see \"Rabeprazole: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F16572477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Bone Fracture Risk with Proton Pump Inhibitors: Health Canada Issues Alert",
"     </span>",
"     <span class=\"collapsible-date\">",
"      April 2013",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Health Canada has informed healthcare professionals that proton pump inhibitors (PPIs) may increase the risk of bone fractures. The risk of fracture was observed to be higher in patients receiving multiple daily doses for &ge;1 year; age, gender, and concomitant health conditions may also be a factor. Patients with risk factors for osteoporosis should be closely monitored and should receive a PPI at the lowest effective dose and for the shortest duration of therapy appropriate for the condition.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For more information, refer to file://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/26523a-eng.php.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10539946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      AcipHex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F216709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Rabeprazole&reg;;",
"     </li>",
"     <li>",
"      Pariet&reg;;",
"     </li>",
"     <li>",
"      Pat-Rabeprazole;",
"     </li>",
"     <li>",
"      PMS-Rabeprazole EC;",
"     </li>",
"     <li>",
"      PRO-Rabeprazole;",
"     </li>",
"     <li>",
"      Rabeprazole EC;",
"     </li>",
"     <li>",
"      RAN&trade;-Rabeprazole;",
"     </li>",
"     <li>",
"      Riva-Rabeprazole EC;",
"     </li>",
"     <li>",
"      Sandoz-Rabeprazole;",
"     </li>",
"     <li>",
"      Teva-Rabeprazole EC",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F216743\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Proton Pump Inhibitor;",
"     </li>",
"     <li>",
"      Substituted Benzimidazole",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F216713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      GERD, erosive/ulcerative:",
"     </b>",
"     Oral: Treatment: 20 mg once daily for 4-8 weeks; if inadequate response, may repeat up to an additional 8 weeks; maintenance: 20 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     Oral: 20 mg once daily for 4 weeks; if inadequate response, may repeat for an additional 4 weeks (lack of symptom control after 4 weeks warrants further evaluation); maintenance: 10 mg once daily (maximum: 20 mg once daily)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      GERD, symptomatic:",
"     </b>",
"     Oral: Treatment: 20 mg once daily for 4 weeks; if inadequate response, may repeat for an additional 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     10 mg once daily (maximum: 20 mg once daily) for 4 weeks; lack of symptom control after 4 weeks warrants further evaluation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Duodenal ulcer:",
"     </b>",
"     Oral: 20 mg daily before breakfast for 4 weeks; additional therapy may be required for some patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gastric ulcers",
"     </b>",
"     (",
"     <i>",
"      Canadian labeling",
"     </i>",
"     ): Oral: 20 mg once daily up to 6 weeks; additional therapy may be required for some patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Helicobacter pylori",
"      </i>",
"     </b>",
"     <b>",
"      eradication:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Manufacturer labeling: 20 mg twice daily administered with amoxicillin 1000 mg",
"     <i>",
"      and",
"     </i>",
"     clarithromycin 500 mg twice daily for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     American College of Gastroenterology guidelines (Chey, 2007):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Nonpenicillin allergy: 20 mg twice daily administered with amoxicillin 1000 mg",
"     <i>",
"      and",
"     </i>",
"     clarithromycin 500 mg twice daily for 10-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Penicillin allergy: 20 mg twice daily administered with clarithromycin 500 mg",
"     <i>",
"      and",
"     </i>",
"     metronidazole 500 mg twice daily for 10-14 days",
"     <b>",
"      or",
"     </b>",
"     20 mg once or twice daily administered with bismuth subsalicylate 525 mg",
"     <i>",
"      and",
"     </i>",
"     metronidazole 250 mg",
"     <i>",
"      plus",
"     </i>",
"     tetracycline 500 mg 4 times/day for 10-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypersecretory conditions:",
"     </b>",
"     Oral: 60 mg once daily; dose may need to be adjusted as necessary. Doses as high as 100 mg once daily and 60 mg twice daily have been used, and continued as long as necessary (up to 1 year in some patients).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      NERD",
"     </b>",
"     (",
"     <i>",
"      Canadian labeling",
"     </i>",
"     ): Oral: Treatment: 10 mg (maximum: 20 mg once daily) for 4 weeks; lack of symptom control after 4 weeks warrants further evaluation",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F6189304\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/44/43718?source=see_link\">",
"      see \"Rabeprazole: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Short-term treatment of  GERD:",
"     </b>",
"     <i>",
"      U.S. labeling:",
"     </i>",
"     Children &ge;12 years: 20 mg once daily for &le;8 weeks",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F216714\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F216715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F216716\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mild-to-moderate: No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Severe: No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied). Use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F216683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, delayed release, enteric coated, oral, as sodium:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     AcipHex&reg;: 20 mg",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F5940143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet, delayed release, enteric coated, as sodium:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Pariet&reg;: 10 mg, 20 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F216669\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F16562879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Aciphex Sprinkle (delayed-release capsule): FDA approved March 2013; anticipated availability currently unknown. Consult prescribing information for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F15386957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     AcipHex&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM324059.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM324059.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F216686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered without regard to meals; best if taken before breakfast. Do not crush, split, or chew tablet. May be administered with an antacid.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F216685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Short-term (4-8 weeks) treatment and maintenance of erosive or ulcerative gastroesophageal reflux disease (GERD); symptomatic GERD; short-term (up to 4 weeks) treatment of duodenal ulcers; long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome;",
"     <i>",
"      H. pylori",
"     </i>",
"     eradication (in combination therapy)",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Canadian labeling: Additional uses (not in U.S. labeling): Treatment of nonerosive reflux disease (NERD); treatment of gastric ulcers",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F216739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Maintenance of healing and prevention of relapse for duodenal ulcer; treatment and prevention of NSAID-induced ulcer",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F216750\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       AcipHex&reg; may be confused with Acephen&trade;, Accupril&reg;, Aricept&reg;, pHisoHex&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       RABEprazole may be confused with ARIPiprazole, donepezil, lansoprazole, omeprazole, raloxifene",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F216741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not always defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Peripheral edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (2% to 10%), pain (3%), dizziness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (2% to 5%), nausea (2% to 5%), abdominal pain (4%), vomiting (4%), flatulence (3%), constipation (2%), xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Hepatic encephalopathy, hepatic enzymes increased, hepatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, myalgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Infection (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Agitation, agranulocytosis, albuminuria, allergic reaction, alopecia, amblyopia, anaphylaxis, anemia, angioedema, bullous skin eruption, chest pain, cholecystitis, cholelithiasis,",
"     <i>",
"      Clostridium difficile",
"     </i>",
"     -associated diarrhea (CDAD), colitis, coma, delirium, disorientation, erythema multiforme, fever, fracture, gynecomastia, hematuria, hemolytic anemia, hyperammonemia, hypertension, hypokalemia, hypomagnesemia, hyponatremia, interstitial nephritis, jaundice, leukocytosis, leukopenia, melena, migraine, osteoporosis-related fracture, palpitation, pancreatitis, pancytopenia, pneumonia, pruritus, rhabdomyolysis, sinus bradycardia, somnolence, Stevens-Johnson syndrome, sudden death, taste abnormal, thrombocytopenia, toxic epidermal necrolysis, TSH increased, weakness",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F216689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to rabeprazole, other substituted benzimidazoles proton pump inhibitors, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F216673\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Atrophic gastritis: Long-term omeprazole therapy has caused atrophic gastritis (by biopsy); this may also occur with rabeprazole.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Carcinoma: No reports of enterochromaffin-like (ECL) cell carcinoids, dysplasia, or neoplasia has occurred.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull;",
"     <i>",
"      Clostridium difficile",
"     </i>",
"     -associated diarrhea (CDAD): Use of proton pump inhibitors (PPIs) may increase risk of CDAD, especially in hospitalized patients; consider CDAD diagnosis in patients with persistent diarrhea that does not improve. Use the lowest dose and shortest duration of PPI therapy appropriate for the condition being treated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fractures: Increased incidence of osteoporosis-related bone fractures of the hip, spine, or wrist may occur with proton pump inhibitor (PPI) therapy. Patients on high-dose (multiple daily doses) or long-term therapy (&ge;1 year) should be monitored. Use the lowest effective dose for the shortest duration of time, use vitamin D and calcium supplementation, and follow appropriate guidelines to reduce risk of fractures in patients at risk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypomagnesemia: Reported rarely, usually with prolonged PPI use of &gt;3 months (most cases &gt;1 year of therapy). May be symptomatic or asymptomatic; severe cases may cause tetany, seizures, and cardiac arrhythmias. Consider obtaining serum magnesium concentrations prior to beginning long-term therapy, especially if taking concomitant digoxin, diuretics, or other drugs known to cause hypomagnesemia; and periodically thereafter.  Hypomagnesemia may be corrected by magnesium supplementation, although discontinuation of rabeprazole may be necessary; magnesium levels typically return to normal within 1 week of stopping.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastric malignancy: Relief of symptoms does not preclude the presence of a gastric malignancy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal infection (eg,",
"     <i>",
"      Salmonella, Campylobacter",
"     </i>",
"     ): Use of proton pump inhibitors may increase risk of these infections.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use caution in patients with severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Clopidogrel: Proton pump inhibitors (PPIs) may diminish the therapeutic effect of clopidogrel, thought to be due to reduced formation of the active metabolite of clopidogrel. The manufacturer of clopidogrel recommends either avoidance of both omeprazole (even when scheduled 12 hours apart) and esomeprazole or use of a PPI with comparatively less effect on the active metabolite of clopidogrel. Avoidance of rabeprazole appears prudent due to potent",
"     <i>",
"      in vitro",
"     </i>",
"     CYP2C19 inhibition (Li, 2004) and lack of sufficient comparative",
"     <i>",
"      in vivo",
"     </i>",
"     studies with other PPIs. In contrast to these warnings, others have recommended the continued use of PPIs, regardless of the degree of inhibition, in patients with a history of GI bleeding or multiple risk factors for GI bleeding who are also receiving clopidogrel since no evidence has established clinically meaningful differences in outcome; however, a clinically-significant interaction cannot be excluded in those who are poor metabolizers of clopidogrel (Abraham, 2010; Levine, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; High potential for other interactions: Concomitant use of rabeprazole with some drugs may require cautious use, may not be recommended, or may require dosage adjustments.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use:",
"     <i>",
"      Helicobacter pylori",
"     </i>",
"     eradication: Short-term combination therapy (&le;7 days) has been associated with a higher incidence of treatment failure. The American College of Gastroenterology recommends 10-14 days of therapy (triple or quadruple) for eradication of",
"     <i>",
"      H. pylori",
"     </i>",
"     (Chey, 2007).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F216736\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C19 (major), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2C19 (weak), CYP2C8 (moderate), CYP2D6 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F216678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Proton Pump Inhibitors may increase the serum concentration of Amphetamines. Specifically, data indicate that Proton Pump Inhibitors may increase the rate at which Amphetamines are absorbed.  Total exposure to Amphetamines is not significantly changed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: Proton Pump Inhibitors may decrease the serum concentration of Atazanavir.  Management: Avoid concurrent PPI in HIV treatment-experienced patients.  For treatment-naive patients, atazanavir/ritonavir dose should be given approximately 12 hours after the PPI, and the PPI should not exceed the equivalent of 20 mg omeprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Proton Pump Inhibitors may diminish the therapeutic effect of Bisphosphonate Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: Proton Pump Inhibitors may decrease the serum concentration of Bosutinib.  Management: Consider alternatives to proton pump inhibitors, such as antacids or H2 receptor antagonists.  Administer alternative agents more than 2 hours before or after bosutinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefditoren: Proton Pump Inhibitors may decrease the serum concentration of Cefditoren.  Management: If possible, avoid use of cefditoren with proton pump inhibitors (PPIs). Consider alternative methods to minimize/control acid reflux (eg, diet modification) or alternative antimicrobial therapy if use of PPIs can not be avoided.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clopidogrel: RABEprazole may decrease serum concentrations of the active metabolite(s) of Clopidogrel.  Management: Due to the possible risk for impaired clopidogrel effectiveness, clinicians should carefully consider the need for proton pump inhibitor therapy in patients receiving clopidogrel.  Other acid-lowering therapies do not appear to share this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inducers (Strong): May increase the metabolism of CYP2C19 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Substrates: CYP2C8 Inhibitors (Moderate) may decrease the metabolism of CYP2C8 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Proton Pump Inhibitors may decrease serum concentrations of the active metabolite(s) of Dabigatran Etexilate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: Proton Pump Inhibitors may decrease the serum concentration of Dasatinib.  Management: Antacids (taken 2 hours before or after dasatinib administration) can be used in place of the proton pump inhibitor if some acid-reducing therapy is needed.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Delavirdine: Proton Pump Inhibitors may decrease the serum concentration of Delavirdine.  Management: Chronic therapy with proton pump inhibitors (PPIs) should be avoided in patients treated with delavirdine.  The clinical significance of short-term PPI therapy with delavirdine is uncertain, but such therapy should be undertaken with caution.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexmethylphenidate: Proton Pump Inhibitors may increase the absorption of Dexmethylphenidate. Specifically, proton pump inhibitors may interfere with the normal release of drug from the extended-release capsules (Focalin XR brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erlotinib: Proton Pump Inhibitors may decrease the serum concentration of Erlotinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May increase the serum concentration of Proton Pump Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gefitinib: Proton Pump Inhibitors may decrease the serum concentration of Gefitinib.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Indinavir: Proton Pump Inhibitors may decrease the serum concentration of Indinavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: Proton Pump Inhibitors may decrease the absorption of Iron Salts.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Itraconazole: Proton Pump Inhibitors may decrease the serum concentration of Itraconazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketoconazole (Systemic): Proton Pump Inhibitors may decrease the serum concentration of Ketoconazole (Systemic). Ketoconazole (Systemic) may increase the serum concentration of Proton Pump Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mesalamine: Proton Pump Inhibitors may diminish the therapeutic effect of Mesalamine. Proton pump inhibitor-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products.  Management: Consider avoiding concurrent administration of high-dose proton pump inhibitors (PPIs) with sustained-release mesalamine products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Proton Pump Inhibitors may increase the serum concentration of Methotrexate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Proton Pump Inhibitors may increase the absorption of Methylphenidate. Specifically, proton pump inhibitors may interfere with the normal release of drug from the extended-release capsules (Ritalin LA brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Proton Pump Inhibitors may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, the absorption of iron may be decreased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Proton Pump Inhibitors may decrease the serum concentration of Mycophenolate. Specifically, concentrations of the active mycophenolic acid may be reduced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nelfinavir: Proton Pump Inhibitors may decrease serum concentrations of the active metabolite(s) of Nelfinavir. Proton Pump Inhibitors may decrease the serum concentration of Nelfinavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nilotinib: Proton Pump Inhibitors may decrease the serum concentration of Nilotinib.  Management: Avoid this combination when possible since separation of doses is not likely to be an adequate method of minimizing the interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ponatinib: Proton Pump Inhibitors may decrease the serum concentration of Ponatinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Posaconazole: Proton Pump Inhibitors may decrease the serum concentration of Posaconazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Raltegravir: Proton Pump Inhibitors may increase the serum concentration of Raltegravir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rilpivirine: Proton Pump Inhibitors may decrease the serum concentration of Rilpivirine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Risedronate: Proton Pump Inhibitors may diminish the therapeutic effect of Risedronate. Proton Pump Inhibitors may increase the serum concentration of Risedronate. This applies specifically to use of delayed-release risedronate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saquinavir: Proton Pump Inhibitors may increase the serum concentration of Saquinavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Proton Pump Inhibitors may increase the serum concentration of Tacrolimus (Systemic).  Management: Tacrolimus dose adjustment may be required. Rabeprazole, pantoprazole, or selected H2-receptor antagonists (i.e., ranitidine or famotidine) may be less likely to interact. Genetic testing may predict patients at highest risk.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May decrease the serum concentration of Proton Pump Inhibitors. These data are derived from studies with Ritonavir-boosted Tipranavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vismodegib: Proton Pump Inhibitors may decrease the serum concentration of Vismodegib.  Management: Carefully consider the need for any medication that increases the pH of the upper GI tract (PPIs, H2RAs, antacids), as these could significantly reduce vismodegib systemic exposure. Vismodegib dose increases are unlikely to compensate for this effect.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: Proton Pump Inhibitors may increase the serum concentration of Voriconazole. Voriconazole may increase the serum concentration of Proton Pump Inhibitors.  Management: In patients receiving omeprazole 40 mg/day or greater, reduce omeprazole dose by half when initiating voriconazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F216705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (may cause gastric mucosal irritation).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: High-fat meals may delay absorption, but C",
"     <sub>",
"      max",
"     </sub>",
"     and AUC are not altered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may increase the metabolism and thus decrease the levels/effects of rabeprazole.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F216680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F216691\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not shown to be teratogenic in animal studies, however, adequate and well-controlled studies have not been done in humans; use during pregnancy only if clearly needed",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F216719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F216692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to meals; best if taken before breakfast.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F2524721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, EC",
"     </b>",
"     (Aciphex Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (30): $347.59",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F216693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aciprazol (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Gastrodine (CN);",
"     </li>",
"     <li>",
"      Pariet (AE, AR, AT, AU, BB, BE, BG, BH, BM, BO, BR, BS, CH, CL, CO, CR, CY, DE, DK, DO, EG, ES, FI, FR, GB, GR, GT, GY, HK, HN, ID, IE, IL, IQ, IR, IT, JM, JO, JP, KP, KW, LB, LY, MX, MY, NI, NL, NZ, OM, PA, PE, PH, PL, PR, PT, PY, QA, RU, SA, SE, SG, SR, SV, SY, TH, TR, TT, TW, UY, VE, YE, ZA);",
"     </li>",
"     <li>",
"      Pipirazol (KP);",
"     </li>",
"     <li>",
"      Rabec (AR, EC);",
"     </li>",
"     <li>",
"      Rabecid (PK);",
"     </li>",
"     <li>",
"      Rabeloc (IN);",
"     </li>",
"     <li>",
"      Raberin (KP);",
"     </li>",
"     <li>",
"      Rabesta (KP);",
"     </li>",
"     <li>",
"      Rabet (KP);",
"     </li>",
"     <li>",
"      Rabeton (KP);",
"     </li>",
"     <li>",
"      Rabiet (KP);",
"     </li>",
"     <li>",
"      Rabister (KP);",
"     </li>",
"     <li>",
"      Uniprazole (PH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F216672\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Potent proton pump inhibitor; suppresses gastric acid secretion by inhibiting the parietal cell H+/K+ ATP pump",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F216688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Within 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed within 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding, serum: ~96%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via CYP3A and 2C19 to inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: ~52%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination (dose dependent): 1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: 2-5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (90% primarily as thioether carboxylic acid metabolites); remainder in feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Abraham NS, Hlatky MA, Antman EM, et al, &ldquo;ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(24):2619-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/21060077/pubmed\" id=\"21060077\" target=\"_blank\">",
"        21060077",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bell AD, Roussin A, Cartier R, et al, &ldquo;The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines,&rdquo;",
"      <i>",
"       Can J Cardiol",
"      </i>",
"      , 2011, 27(Suppl A):1-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/21640290/pubmed\" id=\"21640290\" target=\"_blank\">",
"        21640290",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chey WD, Wong BC, et al, &ldquo;American College of Gastroenterology Guideline on the Management of",
"      <i>",
"       Helicobacter pylori",
"      </i>",
"      Infection,&rdquo;",
"      <i>",
"       Am J Gastroent",
"      </i>",
"      , 2007, 102(8):1808-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/17608775/pubmed\" id=\"17608775\" target=\"_blank\">",
"        17608775",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cockayne SE, Glet RJ, Gawkrodger DJ, et al, &ldquo;Severe Erythrodermic Reactions to the Proton Pump Inhibitors Omeprazole and Lansoprazole,&rdquo;",
"      <i>",
"       Br J Dermatol",
"      </i>",
"      ,1999, 141(1):173-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/10417548/pubmed\" id=\"10417548\" target=\"_blank\">",
"        10417548",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      de Jager CP, Wever PC, Gemen EF, et al, &ldquo;Proton Pump Inhibitor Therapy Predisposes to Community-Acquired",
"      <i>",
"       Streptococcus pneumoniae",
"      </i>",
"      Pneumonia,&rdquo;",
"      <i>",
"       Aliment Pharmacol Ther",
"      </i>",
"      , 2012, 36(10):941-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/23034135/pubmed\" id=\"23034135\" target=\"_blank\">",
"        23034135",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dellinger RP, Levy MM, Rhodes A, et al, &ldquo;Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2013, 41(2):580-637.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/23353941/pubmed\" id=\"23353941\" target=\"_blank\">",
"        23353941",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kahrilas PJ, Shaheen NJ, Vaezi MF, et al, &ldquo;American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease,&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 2008, 135(4):1383-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/18789939/pubmed\" id=\"18789939\" target=\"_blank\">",
"        18789939",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lanza FL, Chan FK, and Quigley EM, &ldquo;Guidelines for Prevention of NSAID-Related Ulcer Complications,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 2009, 140(3):728-38.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/19240698/pubmed\" id=\"19240698\" target=\"_blank\">",
"        19240698",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levine GN, Bates ER, Blankenship JC, et al, &ldquo;2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 124(23):e574-651.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/22064601/pubmed\" id=\"22064601\" target=\"_blank\">",
"        22064601",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Li X-Q, Anderson TB, Ahlstrom M, et al, &ldquo;Comparison of Inhibitory Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole on Human Cytochrome P450 Activities,&rdquo;",
"      <i>",
"       Drug Metab Disp",
"      </i>",
"      , 2004, 32(8):821-7.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Natsch S, Vinks MH, Voogt AK, et al, &ldquo;Anaphylactic Reactions to Proton-Pump Inhibitors,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2000, 34(4):474-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/10772433/pubmed\" id=\"10772433\" target=\"_blank\">",
"        10772433",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Paoluzi P, Iacopini F, Crispino P, et al, &ldquo;2-Week Triple Therapy for",
"      <i>",
"       Helicobacter pylori",
"      </i>",
"      Infection is Better Than 1-Week in Clinical Practice: a Large Prospective Single-Center Randomized Study,&rdquo;",
"      <i>",
"       Helicobacter",
"      </i>",
"      , 2006, 11(6):562-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/17083378/pubmed\" id=\"17083378\" target=\"_blank\">",
"        17083378",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Talley NJ and Vakil N, &ldquo;Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the Management of Dyspepsia,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 2005, 100(10):2324-37.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/18/44327/abstract-text/16181387/pubmed\" id=\"16181387\" target=\"_blank\">",
"        16181387",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wolfe MM and Sachs G, &ldquo;Acid Suppression: Optimizing Therapy for Gastroduodenal Ulcer Healing, Gastroesophageal Reflux Disease, and Stress-Related Erosive Syndrome,&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 2000,118(2 Suppl 1):9-31.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9519 Version 49.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-422ACB6E1F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44327=[""].join("\n");
var outline_f43_18_44327=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16572477\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10539946\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216709\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216743\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216713\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6189304\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216714\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216715\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216716\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216683\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5940143\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216669\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16562879\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15386957\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216686\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216685\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216739\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216750\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216741\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216689\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216673\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216736\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216678\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216705\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216680\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216691\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216719\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216692\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2524721\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216693\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216672\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216688\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9519\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9519|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/44/41668?source=related_link\">",
"      Rabeprazole: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/44/43718?source=related_link\">",
"      Rabeprazole: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_18_44328="Carbon dioxide monitoring (capnography)";
var content_f43_18_44328=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Carbon dioxide monitoring (capnography)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/18/44328/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44328/contributors\">",
"     Baruch Krauss, MD, EdM, FAAP, FACEP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44328/contributors\">",
"     Salvatore Silvestri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44328/contributors\">",
"     Jay L Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/18/44328/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44328/contributors\">",
"     Ron M Walls, MD, FRCPC, FAAEM",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44328/contributors\">",
"     Susan B Torrey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/18/44328/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44328/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/18/44328/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term capnography refers to the noninvasive measurement of the partial pressure of carbon dioxide (CO2) in exhaled breath expressed as the CO2 concentration over time. The relationship of CO2 concentration to time is graphically represented by the CO2 waveform, or capnogram (",
"    <a class=\"graphic graphic_figure graphicRef67700 \" href=\"mobipreview.htm?25/19/25917\">",
"     figure 1",
"    </a>",
"    ). Changes in the shape of the capnogram are diagnostic of disease conditions, while changes in end-tidal CO2 (EtCO2), the maximum CO2 concentration at the end of each tidal breath, can be used to assess disease severity and response to treatment. Capnography is also the most reliable indicator that an endotracheal tube is placed in the trachea after intubation.",
"   </p>",
"   <p>",
"    Oxygenation and ventilation are distinct physiologic functions that must be assessed in both intubated and spontaneously breathing patients. Pulse oximetry provides instantaneous feedback about oxygenation. Capnography provides instantaneous information about ventilation (how effectively CO2 is being eliminated by the pulmonary system), perfusion (how effectively CO2 is being transported through the vascular system), and metabolism (how effectively CO2 is being produced by cellular metabolism).",
"   </p>",
"   <p>",
"    Capnography became a routine part of anesthesia practice in Europe in the 1970s and in the United States in the 1980s. It is now part of the standard of care for all patients receiving general anesthesia and is an emerging standard of care in emergency medical services, emergency medicine, and intensive care.",
"   </p>",
"   <p>",
"    This topic review will discuss the basic physiology and interpretation of capnography and its use in the emergency department.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PRINCIPLES OF OPERATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carbon dioxide (CO2) monitors measure gas concentration, or partial pressure, using one of two configurations: mainstream or sidestream. Mainstream devices measure respiratory gas (in this case CO2) directly from the airway, with the sensor located on the airway adapter at the hub of the endotracheal tube. Sidestream devices measure respiratory gas via nasal or nasal-oral cannula by aspirating a small sample from the exhaled breath through the cannula tubing to a sensor located inside the monitor (",
"    <a class=\"graphic graphic_picture graphicRef62543 \" href=\"mobipreview.htm?14/63/15351\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Mainstream systems are configured for intubated patients. Sidestream systems are configured for both intubated and nonintubated patients.",
"   </p>",
"   <p>",
"    Sidestream systems are configured to use high flow rates (around 150",
"    <span class=\"nowrap\">",
"     cc/min)",
"    </span>",
"    or low flow rates (around 50",
"    <span class=\"nowrap\">",
"     cc/min).",
"    </span>",
"    Flow rates vary according to the amount of CO2 needed in the breath sample to obtain an accurate reading. Low-flow systems have a lower occlusion rate (from moisture or patient secretions) and are accurate in patients with low tidal volumes (eg, neonates, infants, and adult patients with hypoventilation and low tidal volume breathing). Low-flow systems are also resistant to dilution from supplemental oxygen. High-flow systems sampling at &ge;100",
"    <span class=\"nowrap\">",
"     cc/min",
"    </span>",
"    have been shown to be inaccurate in neonates, infants, young children, and in hypoventilating adult patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CO2 monitors are either quantitative or qualitative. Quantitative devices measure the precise end-tidal CO2 (EtCO2) either as a number (capnometry) or a number and a waveform (capnography). Qualitative devices report the range in which the EtCO2 falls (eg, 0 to 10 mmHg or &gt;35 mmHg) as opposed to a precise value (eg, 38 mmHg).",
"   </p>",
"   <p>",
"    The most commonly used qualitative capnometric device is the colorimetric EtCO2 detector. This device consists of a piece of specially treated litmus paper that changes color when exposed to CO2 (purple for EtCO2 &lt;3 mmHg; tan for 3 to 15 mmHg; and yellow for &gt;15 mmHg). Its primary use is for verification of endotracheal tube (ETT) placement. Exhalation of CO2 from an ETT placed in the trachea will change the color of the litmus paper from purple to yellow. An improperly placed ETT in the esophagus will not conduct CO2 and no change will occur in the color of the litmus paper, which will remain purple. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/55/1912?source=see_link&amp;anchor=H13#H13\">",
"     \"Rapid sequence intubation in adults\", section on 'Placement with proof'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Capnography uses infrared (IR) radiation to make measurements. Molecules of CO2 absorb IR radiation at a very specific wavelength (4.26 &micro;m), with the amount of radiation absorbed having a nearly exponential relation to the CO2 concentration present in the breath sample. Detecting these changes in IR radiation levels, using appropriate photo-detectors sensitive in this spectral region, allows for the calculation of the CO2 concentration in the gas sample.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CO2 WAVEFORM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The capnogram consists of four phases (",
"    <a class=\"graphic graphic_figure graphicRef67700 \" href=\"mobipreview.htm?25/19/25917\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Phase 1 (dead space ventilation, A-B) represents the beginning of exhalation where the dead space is cleared from the upper airway.",
"     </li>",
"     <li>",
"      Phase 2 (ascending phase, B-C) represents the rapid rise in CO2 concentration in the breath stream as the CO2 from the alveoli reaches the upper airway.",
"     </li>",
"     <li>",
"      Phase 3 (alveolar plateau, C-D) represents the CO2 concentration reaching a uniform level in the entire breath stream from alveolus to nose. Point D, occurring at the end of the alveolar plateau, represents the maximum CO2 concentration at the end of the tidal breath and is appropriately named the end-tidal CO2 (EtCO2). This is the number that appears on the monitor display.",
"     </li>",
"     <li>",
"      Phase 4 (D-E) represents the inspiratory cycle.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with normal lung function have characteristic rectangular capnograms and narrow gradients between their alveolar CO2 (ie, EtCO2) and arterial CO2 concentration (PaCO2) of 0 to 5 mmHg (",
"    <a class=\"graphic graphic_figure graphicRef67700 \" href=\"mobipreview.htm?25/19/25917\">",
"     figure 1",
"    </a>",
"    ). Gas in the physiologic dead space accounts for this normal gradient.",
"   </p>",
"   <p>",
"    Patients with obstructive lung disease have impaired expiratory flow, and demonstrate a more rounded ascending phase and an upward slope in the alveolar plateau (",
"    <a class=\"graphic graphic_figure graphicRef64586 \" href=\"mobipreview.htm?12/25/12701\">",
"     figure 2",
"    </a>",
"    ). In patients with abnormal lung function and ventilation-perfusion mismatch, the EtCO2-PaCO2 gradient widens depending on the severity of the lung disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The EtCO2 in patients with lung disease is only useful for assessing trends in ventilatory status over time; isolated EtCO2 values may or may not correlate with the PaCO2.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATIONS FOR INTUBATED PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Capnography can be used in intubated patients for:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Verification of endotracheal tube (ETT) placement",
"     </li>",
"     <li>",
"      Continuous monitoring of tube location during transport",
"     </li>",
"     <li>",
"      Gauging effectiveness of resuscitation and prognosis during cardiac arrest",
"     </li>",
"     <li>",
"      Indicator of ROSC during chest compressions",
"     </li>",
"     <li>",
"      Titrating EtCO2 levels in patients with suspected increases in intracranial pressure",
"     </li>",
"     <li>",
"      Determining prognosis in trauma",
"     </li>",
"     <li>",
"      Determining adequacy of ventilation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A table summarizing capnographic findings in different clinical scenarios is provided (",
"    <a class=\"graphic graphic_figure graphicRef78408 graphicRef57493 \" href=\"mobipreview.htm?1/57/1945\">",
"     figure 3A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Verification of ETT placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unrecognized misplaced intubation (UMI) is defined as the placement of an endotracheal tube (ETT) in a location other than the trachea that is unrecognized by the clinician. UMI has disastrous consequences and has been extensively documented in the emergency medical services (EMS) literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/6-13\">",
"     6-13",
"    </a>",
"    ]. In 2001, the first study with a primary outcome of identifying UMI noted an alarming rate of 25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/14\">",
"     14",
"    </a>",
"    ]. Contemporaneous and subsequent EMS studies have reported UMI rates of 7 to 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. UMI is unacceptable and widespread use of CO2 monitoring is an important step toward its elimination.",
"   </p>",
"   <p>",
"    Following intubation, the presence of a waveform with all four phases (",
"    <a class=\"graphic graphic_figure graphicRef67700 \" href=\"mobipreview.htm?25/19/25917\">",
"     figure 1",
"    </a>",
"    ) indicates the ETT is through the vocal cords. A normal waveform can occur when the tube has been placed in the right mainstem bronchus. A flatline waveform generally indicates esophageal placement, but can occur in several other situations, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prolonged cardiac arrest with diffuse cellular death (in which no CO2 is produced because of an absence of cellular respiration and CO2 exchange in the pulmonary bed is severely compromised)",
"     </li>",
"     <li>",
"      Tracheal placement with inadequate pulmonary blood flow (eg, poor chest compressions)",
"     </li>",
"     <li>",
"      ETT obstruction",
"     </li>",
"     <li>",
"      Complete airway obstruction distal to the ETT (eg, foreign body)",
"     </li>",
"     <li>",
"      Technical malfunction of the monitor or tubing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The accuracy of EtCO2 to confirm tracheal location of an ETT varies with the technology used and the condition of the patient. For patients who are not in cardiac arrest, studies of qualitative colorimetric EtCO2 and quantitative capnography have demonstrated 100 percent sensitivity and 100 percent specificity for tracheal placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/19-24\">",
"     19-24",
"    </a>",
"    ]. In contrast, clinical assessment using physical signs is unreliable for determining ETT location. Fogging or condensation of the tube occurs in 83 percent of esophageal intubations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/25\">",
"     25",
"    </a>",
"    ], and chest wall movement can be produced by tracheal or esophageal tubes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/26\">",
"     26",
"    </a>",
"    ]. Anesthesiologists, under ideal operating room conditions, using breath sounds as the sole means of verification, incorrectly identify ETT location in 16 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the accuracy of EtCO2 for verifying ETT placement in patients with spontaneous circulation approaches 100 percent, sensitivities for tracheal placement vary greatly in cardiac arrest patients, ranging from 62 to 100 percent, depending on the modality used and the duration of the arrest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/4,5,10,21,22,25-28\">",
"     4,5,10,21,22,25-28",
"    </a>",
"    ]. In patients with low perfusion states, studies using quantitative modalities (ie, capnography) for determining tracheal location of the ETT have shown 100 percent sensitivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Studies using qualitative (ie, colorimetric) EtCO2 methods have shown variable sensitivity, because the exhaled CO2 concentration can fall below the detection threshold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/10,21,22,27\">",
"     10,21,22,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Capnography appears to be highly accurate in determining ETT location, and we advocate its use in",
"    <strong>",
"     ALL",
"    </strong>",
"    patients who are intubated. Physical assessment and assessment of capnographic waveform should be considered co-primary methods of verifying ETT placement. Nevertheless, the small number of esophageal intubations in studies assessing the accuracy of capnography for determining ETT placement in cardiac arrest patients limits the strength of these studies. Capnography's true specificity for detecting esophageal intubation in cardiac arrest patients is not certain.",
"   </p>",
"   <p>",
"    When capnography provides a waveform for an intubated patient in cardiac arrest, the ETT can be assumed to be within the trachea. An absent (flatline) waveform may indicate esophageal placement or tracheal placement with complete circulatory failure. Early in cardiac arrest, and when the patient is receiving effective CPR, complete failure of CO2 exchange is unlikely, and the clinician should assume esophageal intubation exists if a waveform is absent. In patients with prolonged cardiac arrest and an absent waveform, the clinician should assume an esophageal intubation exists or use an alternative objective method for tube verification, such as an aspiration method. Physical examination criteria, such as repeat laryngoscopy and auscultation of the lungs and epigastrium, may be used, but the clinician must be aware of their limitations in discriminating between esophageal and tracheal intubation. Algorithms for ETT verification are provided (",
"    <a class=\"graphic graphic_algorithm graphicRef71442 graphicRef58659 \" href=\"mobipreview.htm?31/27/32177\">",
"     algorithm 1A-B",
"    </a>",
"    ). Other methods for verifying ETT placement, including the aspiration technique, are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/55/1912?source=see_link&amp;anchor=H13#H13\">",
"     \"Rapid sequence intubation in adults\", section on 'Placement with proof'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to verification and monitoring of ETT placement, capnography provides similar information about the placement of alternate advanced airway devices (laryngeal tube airway, laryngeal mask airway, esophageal-tracheal combitube).",
"   </p>",
"   <p>",
"    It is essential when evaluating studies of EtCO2 to distinguish those involving qualitative measurements (colorimetric) from those describing quantitative methods with a graphic waveform display (capnography).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Monitoring ETT location during transport",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unrecognized misplaced intubation (UMI) has catastrophic consequences, and can occur when an endotracheal tube (ETT) is dislodged during patient transport. Continuous monitoring of ETT location during transport can prevent UMI. End-tidal CO2 (EtCO2) confirmation of initial endotracheal tube placement and continuous capnographic monitoring of ETT location is an accepted standard of care by the American Society of Anesthesiologists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/32\">",
"     32",
"    </a>",
"    ] and is recommended as the most reliable method by other national organizations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/33-35\">",
"     33-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prospective, observational study of 153 prehospital intubations found a 23 percent UMI rate among patients without continuous EtCO2 monitoring, while patients with continuously monitored EtCO2 sustained the desired 0 percent UMI rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/18\">",
"     18",
"    </a>",
"    ]. The attached figures depict one airway confirmation algorithm using colorimetric CO2 detectors and another using capnography. They can be used for both prehospital and in-hospital intubated patients (",
"    <a class=\"graphic graphic_algorithm graphicRef71442 graphicRef58659 \" href=\"mobipreview.htm?31/27/32177\">",
"     algorithm 1A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Effectiveness of CPR",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the 1980s, studies using animal models showed that end-tidal CO2 (EtCO2) levels reflect cardiac output during cardiopulmonary resuscitation (CPR) and can be used as a noninvasive measure of cardiac output. A landmark study in 1988 demonstrated this principle in humans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/36\">",
"     36",
"    </a>",
"    ]. During cardiac arrest, when alveolar ventilation and metabolism are essentially constant, EtCO2 reflects pulmonary blood flow. Therefore, EtCO2 can be used as a gauge of the effectiveness of cardiac compressions. As effective CPR leads to a higher cardiac output, EtCO2 will rise, reflecting the increase in perfusion.",
"   </p>",
"   <p>",
"    The measurement of EtCO2 varies directly with the cardiac output produced by chest compression and has been described in both EMS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/37\">",
"     37",
"    </a>",
"    ] and ICU patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/36\">",
"     36",
"    </a>",
"    ]. Both of these prospective, observational studies found an EtCO2 level &lt;3 mmHg immediately after cardiac arrest, with a higher level generated during cardiac compressions and a mean peak &gt;7.5 mmHg just before return of spontaneous circulation (ROSC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. This peak in EtCO2 level is the earliest sign of ROSC and may occur before return of a palpable pulse or blood pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Return of spontaneous circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;During cardiac arrest, EtCO2 is the earliest indicator of the return of spontaneous circulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. When the heart restarts, the dramatic increase in cardiac output, and resulting increase in perfusion, leads to a rapid increase in EtCO2 as the CO2 that has accumulated during cardiac arrest is effectively transported to the lungs and exhaled. This process manifests as a sudden rise in EtCO2. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Effectiveness of CPR'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    American Heart Association (AHA) guidelines for cardiac resuscitation emphasize the importance of continuing chest compressions without interruption until a perfusing rhythm is reestablished. Experimental evidence indicates that interruptions in chest compressions are followed by sustained periods of reduced blood flow, which only gradually return to preinterruption levels. Capnographic waveform monitoring virtually eliminates the need to stop chest compressions to check for pulses. Reestablishment of a perfusing rhythm is accompanied immediately by a dramatic increase in EtCO2. Once this rise in EtCO2 is noted, chest compressions can safely be stopped while cardiac rhythm and blood pressure are assessed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/35,38\">",
"     35,38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/25/36248?source=see_link\">",
"     \"Basic life support (BLS) in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Prognosis in cardiac arrest",
"    </span>",
"    &nbsp;&mdash;&nbsp;In several prospective, observational studies, EtCO2 levels of &le;10 mmHg measured 20 minutes after the initiation of advanced cardiac life support accurately predicted death in adult patients with cardiac arrest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/39-42\">",
"     39-42",
"    </a>",
"    ]. The prognostic value of measuring EtCO2 has been demonstrated in animal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/43\">",
"     43",
"    </a>",
"    ] and human studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/39-42,44\">",
"     39-42,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cause of cardiac arrest",
"    </span>",
"    &nbsp;&mdash;&nbsp;EtCO2 may also be helpful in determining the etiology of cardiac arrest. Two animal studies reported higher EtCO2 levels at the onset of cardiac arrest caused by primary asphyxia than arrest caused by ventricular fibrillation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Researchers found results consistent with these animal experiments in a prospective, observational study of prehospital victims of cardiac arrest. Patients in the asphyxia group (initial rhythm of asystole or pulseless electrical activity associated with conditions such as airway foreign body, aspiration, asthma, or drowning) had higher EtCO2 levels compared with patients in the ventricular",
"    <span class=\"nowrap\">",
"     tachycardia/fibrillation",
"    </span>",
"    group (initial rhythm of ventricular",
"    <span class=\"nowrap\">",
"     tachycardia/fibrillation",
"    </span>",
"    associated with acute myocardial infarction) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Increased ICP and trauma prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;End-tidal CO2 (EtCO2) monitoring can help clinicians avoid inadvertent hyperventilation of patients with head injury and suspected increased intracranial pressure (ICP). It may also help determine the prognosis of trauma victims.",
"   </p>",
"   <p>",
"    Arterial CO2 tension affects blood flow to the brain. High CO2 levels result in cerebral vasodilation, while low CO2 levels result in cerebral vasoconstriction. Sustained hypoventilation (defined as PaCO2 levels &ge;50 mmHg) results in increased cerebral blood flow and increased ICP, which can harm head-injured patients. Sustained hyperventilation (defined as PaCO2 &le;30 mmHg) is also detrimental and is associated with worse neurologic outcome in severely brain-injured patients. Consequently, ventilation rates to achieve eucapnia are recommended by the brain trauma foundation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of continuous EtCO2 monitoring in trauma patients is supported by several studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective observational study found a lower incidence of inadvertent hyperventilation among intubated patients with severe head injury who underwent continuous EtCO2 monitoring compared with those without EtCO2 monitoring (5.6 versus 13.4 percent; OR 2.64; 95% CI 1.12-6.20) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a controlled study of intubated blunt trauma victims, patients assigned to capnography-guided ventilation during transport were significantly more likely to arrive at the emergency department appropriately ventilated, based on PaCO2 levels obtained by arterial blood gas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective observational study of blunt trauma patients requiring prehospital intubation, EtCO2 values obtained 20 minutes after intubation distinguished the great majority of survivors from nonsurvivors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/51\">",
"       51",
"      </a>",
"      ]. Median EtCO2 among survivors was 30.8 mmHg and among nonsurvivors 26.3 mmHg (95 percent CI of difference between medians 3 to 6.75 mmHg).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATIONS FOR SPONTANEOUSLY BREATHING PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In spontaneously breathing, nonintubated patient capnography can be used for:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Performing rapid assessment of critically ill or seizing patients",
"     </li>",
"     <li>",
"      Determining response to treatment in acute respiratory distress",
"     </li>",
"     <li>",
"      Determining adequacy of ventilation in obtunded or unconscious patients, or in patients undergoing procedural sedation",
"     </li>",
"     <li>",
"      Detecting metabolic acidosis in diabetic patients and in children with gastroenteritis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A table summarizing capnographic findings in different clinical scenarios is provided (",
"    <a class=\"graphic graphic_figure graphicRef78408 graphicRef57493 \" href=\"mobipreview.htm?1/57/1945\">",
"     figure 3A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Critical illness and seizure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The airway, breathing, and circulation (ABCs) of critically ill patients can be rapidly assessed using the capnography waveform and end-tidal CO2 (EtCO2) values [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/52\">",
"     52",
"    </a>",
"    ]. The presence of a normal waveform denotes a patent airway and spontaneous breathing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/53\">",
"     53",
"    </a>",
"    ]. Normal EtCO2 levels (35 to 45 mmHg) signify adequate perfusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/36,54\">",
"     36,54",
"    </a>",
"    ]. Capnography can be used to assess unresponsive patients ranging from those who are actively seizing to victims of chemical terrorism (",
"    <a class=\"graphic graphic_table graphicRef50827 \" href=\"mobipreview.htm?0/8/138\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/55\">",
"     55",
"    </a>",
"    ]. Unlike pulse oximetry, capnography does not misinterpret motion artifact and provides reliable readings in low perfusion states.",
"   </p>",
"   <p>",
"    Capnography is the only monitoring modality that is accurate and reliable in actively seizing patients because the capnographic waveform is determined entirely by respiratory activity and is not confounded by muscle activity or movement artifact. Capnographic data (respiratory rate, EtCO2, and capnogram) can be used to distinguish among:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Seizing patients with apnea (flatline waveform, no EtCO2 readings, and no chest wall movement)",
"     </li>",
"     <li>",
"      Seizing patients with ineffective ventilation (small waveforms, low EtCO2 values), and",
"     </li>",
"     <li>",
"      Seizing patients with effective ventilation (normal CO2 waveform, EtCO2 values).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Acute respiratory distress",
"    </span>",
"    &nbsp;&mdash;&nbsp;Capnography provides dynamic monitoring of ventilatory status in patients with acute respiratory distress from any cause, including: bronchiolitis, croup, asthma, cystic fibrosis, heart failure, and chronic obstructive pulmonary disease.",
"   </p>",
"   <p>",
"    By measuring end-tidal CO2 (EtCO2) and respiratory rate with each breath, capnography provides instantaneous feedback on the clinical status of the patient. Respiratory rate is measured directly from the airway (nose and mouth) with oral or nasal cannula, providing a more reliable reading than impedance respiratory monitoring. In upper airway obstruction and laryngospasm, impedance monitoring detects chest wall movement, interprets this as a valid breath, and displays a respiratory rate, even though the patient is not ventilating. In contrast, capnography detects no ventilation and shows a flatline waveform.",
"   </p>",
"   <p>",
"    Clinicians can rapidly assess EtCO2 trends. A patient with a respiratory rate of 30 will generate 150 EtCO2 readings in five minutes. This provides sufficient information to determine whether the patient's ventilation is worsening despite treatment (increasing EtCO2), stabilizing (stable EtCO2), or improving (decreasing EtCO2). As an example, increasing EtCO2 would reflect the worsening ventilation of an acutely tachypneic patient with obstructive lung disease who is developing respiratory muscle fatigue or a more severe lower airway obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Procedural sedation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Capnography can rapidly detect the common adverse airway and respiratory events associated with procedural sedation and analgesia (PSA), including: apnea, upper airway obstruction, laryngospasm, bronchospasm, and respiratory depression (",
"    <a class=\"graphic graphic_table graphicRef77403 \" href=\"mobipreview.htm?5/52/5963\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/55-60\">",
"     55-60",
"    </a>",
"    ]. Respiratory depression caused by oversedation will manifest an abnormally high or low EtCO2 well before pulse oximetry detects a falling oxyhemoglobin saturation, especially in patients receiving supplemental oxygen. In one randomized trial, the median time between the onset of respiratory depression, as determined by EtCO2, and hypoxia was 60 seconds (range 5 to 240 seconds) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The combination of absent chest wall movement and a flat-line waveform differentiates apnea from upper airway obstruction or laryngospasm, both of which manifest chest wall movement. Response to airway alignment maneuvers (eg, chin lift, jaw thrust) can often distinguish upper airway obstruction from laryngospasm. The appearance of the characteristic curved capnogram of obstructive lung disease in patients without chronic lung disease indicates bronchospasm (",
"    <a class=\"graphic graphic_figure graphicRef64586 \" href=\"mobipreview.htm?12/25/12701\">",
"     figure 2",
"    </a>",
"    ). EtCO2 levels greater than 70 mmHg in patients without COPD indicate respiratory failure.",
"   </p>",
"   <p>",
"    In three randomized controlled trials, two performed in the emergency department and another in the endoscopy suite, patients monitored with capnography in addition to standard care experienced significantly fewer episodes of hypoxia than those monitored in standard fashion without capnography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of note, the administration of supplemental oxygen renders pulse oximetry ineffective as an early warning device for respiratory depression during PSA. Thus, capnography is strongly encouraged when supplemental oxygen is used, as its readings are not affected by the presence or absence of additional oxygen. The performance of PSA is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=see_link\">",
"     \"Procedural sedation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/23/43384?source=see_link\">",
"     \"Procedural sedation in children outside of the operating room\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Ventilation in obtunded or unconscious patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with altered mental status, including those with alcohol intoxication, intentional or unintentional drug overdose, and postictal patients (especially those treated with benzodiazepines), may have impaired ventilatory function. Capnography can differentiate between patients with effective ventilation and those with ineffective ventilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Detecting metabolic acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a linear correlation between serum bicarbonate (HCO3) and end-tidal CO2 (EtCO2) in pediatric patients with diabetic ketoacidosis and gastroenteritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44328/abstract/63-65\">",
"     63-65",
"    </a>",
"    ]. As the patient becomes acidotic, HCO3 decreases, causing an increase in minute ventilation, which results in a compensatory respiratory alkalosis. This process results in a decrease in EtCO2.",
"   </p>",
"   <p>",
"    By increasing minute ventilation, these patients are able to lower arterial CO2 tension to help correct their underlying acidemia. The more acidotic the patient, the lower the HCO3, the higher the respiratory rate, and the lower the EtCO2. Capnography can be used as an indicator of metabolic acidosis in these patients. In addition, EtCO2 can be used to distinguish diabetics in ketoacidosis (metabolic acidosis, compensatory tachypnea, and low EtCO2) from those who are not (nonacidotic, normal respiratory rate, and normal EtCO2).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     LIMITATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Capnography is most effective when assessing a pure ventilation, perfusion, or metabolism problem. Capnographic findings in mixed ventilation, perfusion, or metabolism problems are difficult to interpret. In patients with complex pathophysiology, a ventilation problem may elevate EtCO2, while a perfusion problem may simultaneously lower EtCO2. As an example, capnography may not provide useful information in a patient with acute pulmonary edema (ventilation problem) from an underlying acute myocardial infarction with decreased cardiac output (perfusion problem).",
"   </p>",
"   <p>",
"    In high-flow CO2 systems, when the tidal volume of the patient drops below the flow rate of the system, the monitor will entrain room air to compensate, falsely diluting the EtCO2 reading and slurring the ascending phase of the waveform. For this and other reasons, low flow systems are preferred. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Principles of operation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Early capnography devices had some difficulty providing consistent measurements in mouth breathing patients and patients who alternated between mouth and nose breathing. The oral-nasal airway interface in more recent monitors no longer has such problems.",
"   </p>",
"   <p>",
"    Capnography is reported to have 100 percent specificity for tracheal placement of the endotracheal tube in cardiac arrest. Its sensitivity for esophageal placement in cardiac arrest is uncertain. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Verification of ETT placement'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carbon dioxide (CO2) monitoring is a versatile noninvasive diagnostic tool for continuous assessment of the ventilatory status of both intubated and nonintubated patients. Capnography provides instantaneous information about ventilation (how effectively CO2 is being eliminated by the pulmonary system), perfusion (how effectively CO2 is being transported through the vascular system), and metabolism (how effectively CO2 is being produced by cellular metabolism). A table summarizing capnographic findings in different clinical scenarios is provided (",
"    <a class=\"graphic graphic_figure graphicRef78408 graphicRef57493 \" href=\"mobipreview.htm?1/57/1945\">",
"     figure 3A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Colorimetric detectors provide a qualitative measurement of end-tidal CO2 (EtCO2); capnometry provides a quantitative EtCO2 measurement; capnography provides a quantitative measure and a waveform depicting CO2 levels over time. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Principles of operation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The capnogram consists of four phases, which are described further above (",
"      <a class=\"graphic graphic_figure graphicRef67700 \" href=\"mobipreview.htm?25/19/25917\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'CO2 Waveform'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Capnography is of greatest value for emergency departments and emergency medical services for confirming placement of endotracheal tubes, continuous monitoring of tube position during transport, assessing the status of patients in cardiac arrest, and monitoring the respiratory status of patients undergoing procedural sedation. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Verification of ETT placement'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Effectiveness of CPR'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Return of spontaneous circulation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Procedural sedation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that an EtCO2 monitor be used to help confirm proper placement of the endotracheal tube (ETT) in",
"      <strong>",
"       ALL",
"      </strong>",
"      intubated patients (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). EtCO2 monitoring is the primary means of confirming tracheal placement of the ETT. Clinical techniques may be used adjunctively, but all have significant limitations in discriminating between esophageal and tracheal intubation (",
"      <a class=\"graphic graphic_algorithm graphicRef71442 graphicRef58659 \" href=\"mobipreview.htm?31/27/32177\">",
"       algorithm 1A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Verification of ETT placement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following intubation, the presence of a waveform with all four phases (",
"      <a class=\"graphic graphic_figure graphicRef67700 \" href=\"mobipreview.htm?25/19/25917\">",
"       figure 1",
"      </a>",
"      ) is a highly accurate indication that the ETT is placed in the trachea. A flatline waveform generally indicates esophageal placement, but can occur with: prolonged cardiac arrest (in which no CO2 exchange occurs), tracheal placement without adequate blood flow (eg, ineffective chest compressions), ETT obstruction, complete airway obstruction distal to the ETT (eg, foreign body), and technical malfunction of the monitor or tubing. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Verification of ETT placement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The sensitivity of capnography for detecting esophageal intubation in cardiac arrest is not certain. When verifying ETT location in cardiac arrest patients, clinicians should assume an esophageal intubation exists whenever there is no detectable CO2 by waveform or qualitative EtCO2 detection. In such circumstances, we suggest clinicians use an alternative objective method of tube placement confirmation, such as an aspiration method (",
"      <a class=\"graphic graphic_algorithm graphicRef71442 graphicRef58659 \" href=\"mobipreview.htm?31/27/32177\">",
"       algorithm 1A-B",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Neither colorimetry nor capnometry provides adequate accuracy for tracheal placement in cardiac arrest patients in whom CO2 is not detected. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Verification of ETT placement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      EtCO2 monitoring can be performed on patients in cardiac arrest to determine the adequacy of chest compressions and the return of spontaneous circulation. During cardiac arrest, EtCO2 reflects pulmonary blood flow and can be used as a gauge of the effectiveness of cardiac compressions. As effective CPR leads to a higher cardiac output, EtCO2 will rise. EtCO2 is also the earliest indicator of the return of spontaneous circulation. When the heart restarts, the dramatic increase in cardiac output, and resulting increase in perfusion, leads to a rapid increase in EtCO2. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Effectiveness of CPR'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Return of spontaneous circulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that capnographic monitoring be performed in patients undergoing procedural sedation, particularly deep sedation (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Capnography can rapidly detect the common adverse airway and respiratory events associated with procedural sedation and analgesia (PSA), including: apnea, upper airway obstruction, laryngospasm, bronchospasm, and respiratory failure (",
"      <a class=\"graphic graphic_table graphicRef77403 \" href=\"mobipreview.htm?5/52/5963\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Procedural sedation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Capnography can be helpful in monitoring the status of patients with seizures, acute respiratory distress, unconsciousness, and metabolic acidosis. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Critical illness and seizure'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Acute respiratory distress'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Ventilation in obtunded or unconscious patients'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Detecting metabolic acidosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Capnography is most effective when assessing a pure ventilation, perfusion, or metabolism problem. Capnographic findings in mixed ventilation, perfusion, or metabolism problems are difficult to interpret. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Limitations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DISCLOSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Baruch Krauss, MD, an author of this topic review, is a consultant for Oridion Medical, a capnography company, and holds two patents in the area of capnography.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/1\">",
"      Friesen RH, Alswang M. End-tidal PCO2 monitoring via nasal cannulae in pediatric patients: accuracy and sources of error. J Clin Monit 1996; 12:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/2\">",
"      Gravenstein N. Capnometry in infants should not be done at lower sampling flow rates. J Clin Monit 1989; 5:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/3\">",
"      Sasse FJ. Can we trust end-tidal carbon dioxide measurements in infants? J Clin Monit 1985; 1:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/4\">",
"      Yamanaka MK, Sue DY. Comparison of arterial-end-tidal PCO2 difference and dead space/tidal volume ratio in respiratory failure. Chest 1987; 92:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/5\">",
"      Hardman JG, Aitkenhead AR. Estimating alveolar dead space from the arterial to end-tidal CO(2) gradient: a modeling analysis. Anesth Analg 2003; 97:1846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/6\">",
"      Stewart RD, Paris PM, Winter PM, et al. Field endotracheal intubation by paramedical personnel. Success rates and complications. Chest 1984; 85:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/7\">",
"      Shea SR, MacDonald JR, Gruzinski G. Prehospital endotracheal tube airway or esophageal gastric tube airway: a critical comparison. Ann Emerg Med 1985; 14:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/8\">",
"      Pointer JE. Clinical characteristics of paramedics' performance of endotracheal intubation. J Emerg Med 1988; 6:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/9\">",
"      Jenkins WA, Verdile VP, Paris PM. The syringe aspiration technique to verify endotracheal tube position. Am J Emerg Med 1994; 12:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/10\">",
"      Bozeman WP, Hexter D, Liang HK, Kelen GD. Esophageal detector device versus detection of end-tidal carbon dioxide level in emergency intubation. Ann Emerg Med 1996; 27:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/11\">",
"      Sayre MR, Sakles JC, Mistler AF, et al. Field trial of endotracheal intubation by basic EMTs. Ann Emerg Med 1998; 31:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/12\">",
"      Eckstein M, Chan L, Schneir A, Palmer R. Effect of prehospital advanced life support on outcomes of major trauma patients. J Trauma 2000; 48:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/13\">",
"      Wang HE, Sweeney TA, O'Connor RE, Rubinstein H. Failed prehospital intubations: an analysis of emergency department courses and outcomes. Prehosp Emerg Care 2001; 5:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/14\">",
"      Katz SH, Falk JL. Misplaced endotracheal tubes by paramedics in an urban emergency medical services system. Ann Emerg Med 2001; 37:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/15\">",
"      Gausche M, Lewis RJ, Stratton SJ, et al. Effect of out-of-hospital pediatric endotracheal intubation on survival and neurological outcome: a controlled clinical trial. JAMA 2000; 283:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/16\">",
"      Jones JH, Murphy MP, Dickson RL, et al. Emergency physician-verified out-of-hospital intubation: miss rates by paramedics. Acad Emerg Med 2004; 11:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/17\">",
"      Jemmett ME, Kendal KM, Fourre MW, Burton JH. Unrecognized misplacement of endotracheal tubes in a mixed urban to rural emergency medical services setting. Acad Emerg Med 2003; 10:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/18\">",
"      Silvestri S, Ralls GA, Krauss B, et al. The effectiveness of out-of-hospital use of continuous end-tidal carbon dioxide monitoring on the rate of unrecognized misplaced intubation within a regional emergency medical services system. Ann Emerg Med 2005; 45:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/19\">",
"      Goldberg JS, Rawle PR, Zehnder JL, Sladen RN. Colorimetric end-tidal carbon dioxide monitoring for tracheal intubation. Anesth Analg 1990; 70:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/20\">",
"      Knapp S, Kofler J, Stoiser B, et al. The assessment of four different methods to verify tracheal tube placement in the critical care setting. Anesth Analg 1999; 88:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/21\">",
"      Ornato JP, Shipley JB, Racht EM, et al. Multicenter study of a portable, hand-size, colorimetric end-tidal carbon dioxide detection device. Ann Emerg Med 1992; 21:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/22\">",
"      MacLeod BA, Heller MB, Gerard J, et al. Verification of endotracheal tube placement with colorimetric end-tidal CO2 detection. Ann Emerg Med 1991; 20:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/23\">",
"      Vukmir RB, Heller MB, Stein KL. Confirmation of endotracheal tube placement: a miniaturized infrared qualitative CO2 detector. Ann Emerg Med 1991; 20:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/24\">",
"      Grmec S, Mally S. Prehospital determination of tracheal tube placement in severe head injury. Emerg Med J 2004; 21:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/25\">",
"      Kelly JJ, Eynon CA, Kaplan JL, et al. Use of tube condensation as an indicator of endotracheal tube placement. Ann Emerg Med 1998; 31:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/26\">",
"      Pollard BJ, Junius F. Accidental intubation of the oesophagus. Anaesth Intensive Care 1980; 8:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/27\">",
"      Birmingham PK, Cheney FW, Ward RJ. Esophageal intubation: a review of detection techniques. Anesth Analg 1986; 65:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/28\">",
"      Bhende MS, Thompson AE. Evaluation of an end-tidal CO2 detector during pediatric cardiopulmonary resuscitation. Pediatrics 1995; 95:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/29\">",
"      Sayah AJ, Peacock WF, Overton DT. End-tidal CO2 measurement in the detection of esophageal intubation during cardiac arrest. Ann Emerg Med 1990; 19:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/30\">",
"      Krauss B, Ralls G, et al. Emergency Department Capnographic Confirmation of Prehospital Endotracheal Intubation in Cardiac Arrest Patients - A Preliminary Report. Ann Emerg Med 2005; 46:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/31\">",
"      Grmec S. Comparison of three different methods to confirm tracheal tube placement in emergency intubation. Intensive Care Med 2002; 28:701.",
"     </a>",
"    </li>",
"    <li>",
"     American Society of Anesthesiologists. Basic Standards for Preanesthesia Care 1999. American Society of Anesthesiologists: Standards for basic anesthetic monitoring. file://www.asahq.org/publicationsAndServices/standards/32.html (Accessed on April 16, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/33\">",
"      O'Connor RE, Swor RA. Verification of endotracheal tube placement following intubation. National Association of EMS Physicians Standards and Clinical Practice Committee. Prehosp Emerg Care 1999; 3:248.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Emergency Physicians Policy Statement. Verification of Endotracheal Tube Placement. file://www.acep.org/webportal/PracticeResources/PolicyStatements/pracmgt/VerificationofEndotrachealTubePlacement.htm (Accessed on April 16, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/35\">",
"      Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/36\">",
"      Falk JL, Rackow EC, Weil MH. End-tidal carbon dioxide concentration during cardiopulmonary resuscitation. N Engl J Med 1988; 318:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/37\">",
"      Garnett AR, Ornato JP, Gonzalez ER, Johnson EB. End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation. JAMA 1987; 257:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/38\">",
"      2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Part 7.1: Adjuncts for airway control and ventilation. Circulation 2005; 112(suppl IV):IV-51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/39\">",
"      Sanders AB, Kern KB, Otto CW, et al. End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation. A prognostic indicator for survival. JAMA 1989; 262:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/40\">",
"      Levine RL, Wayne MA, Miller CC. End-tidal carbon dioxide and outcome of out-of-hospital cardiac arrest. N Engl J Med 1997; 337:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/41\">",
"      Wayne MA, Levine RL, Miller CC. Use of end-tidal carbon dioxide to predict outcome in prehospital cardiac arrest. Ann Emerg Med 1995; 25:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/42\">",
"      Grmec S, Klemen P. Does the end-tidal carbon dioxide (EtCO2) concentration have prognostic value during out-of-hospital cardiac arrest? Eur J Emerg Med 2001; 8:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/43\">",
"      Sanders AB, Ewy GA, Bragg S, et al. Expired PCO2 as a prognostic indicator of successful resuscitation from cardiac arrest. Ann Emerg Med 1985; 14:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/44\">",
"      Asplin BR, White RD. Prognostic value of end-tidal carbon dioxide pressures during out-of-hospital cardiac arrest. Ann Emerg Med 1995; 25:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/45\">",
"      Bhende MS, Karasic DG, Karasic RB. End-tidal carbon dioxide changes during cardiopulmonary resuscitation after experimental asphyxial cardiac arrest. Am J Emerg Med 1996; 14:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/46\">",
"      Berg RA, Henry C, Otto CW, et al. Initial end-tidal CO2 is markedly elevated during cardiopulmonary resuscitation after asphyxial cardiac arrest. Pediatr Emerg Care 1996; 12:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/47\">",
"      Grmec S, Lah K, Tusek-Bunc K. Difference in end-tidal CO2 between asphyxia cardiac arrest and ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest in the prehospital setting. Crit Care 2003; 7:R139.",
"     </a>",
"    </li>",
"    <li>",
"     Brain Trauma Foundation. Management and prognosis of severe traumatic brain injury guidelines. file://www2.braintrauma.org/guidelines/downloads/btf_guidelines_management.pdf (Accessed on April 29, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/49\">",
"      Davis DP, Dunford JV, Ochs M, et al. The use of quantitative end-tidal capnometry to avoid inadvertent severe hyperventilation in patients with head injury after paramedic rapid sequence intubation. J Trauma 2004; 56:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/50\">",
"      Helm M, Schuster R, Hauke J, Lampl L. Tight control of prehospital ventilation by capnography in major trauma victims. Br J Anaesth 2003; 90:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/51\">",
"      Deakin CD, Sado DM, Coats TJ, Davies G. Prehospital end-tidal carbon dioxide concentration and outcome in major trauma. J Trauma 2004; 57:65.",
"     </a>",
"    </li>",
"    <li>",
"     Miller RD. Miller's Anesthesia, 6th, Elsevier Churchill Livingstone, New York 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/53\">",
"      Swedlow, DB. Capnometry and capnography: The anesthesia disaster early warning system. Seminars in Anesthesia 1986; 3:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/54\">",
"      Weil MH, Bisera J, Trevino RP, Rackow EC. Cardiac output and end-tidal carbon dioxide. Crit Care Med 1985; 13:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/55\">",
"      Krauss B. Capnography as a rapid assessment and triage tool for chemical terrorism. Pediatr Emerg Care 2005; 21:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/56\">",
"      Krauss B, Hess DR. Capnography for procedural sedation and analgesia in the emergency department. Ann Emerg Med 2007; 50:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/57\">",
"      Hart LS, Berns SD, Houck CS, Boenning DA. The value of end-tidal CO2 monitoring when comparing three methods of conscious sedation for children undergoing painful procedures in the emergency department. Pediatr Emerg Care 1997; 13:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/58\">",
"      Miner JR, Heegaard W, Plummer D. End-tidal carbon dioxide monitoring during procedural sedation. Acad Emerg Med 2002; 9:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/59\">",
"      Burton JH, Harrah JD, Germann CA, Dillon DC. Does end-tidal carbon dioxide monitoring detect respiratory events prior to current sedation monitoring practices? Acad Emerg Med 2006; 13:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/60\">",
"      Lightdale JR, Goldmann DA, Feldman HA, et al. Microstream capnography improves patient monitoring during moderate sedation: a randomized, controlled trial. Pediatrics 2006; 117:e1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/61\">",
"      Deitch K, Miner J, Chudnofsky CR, et al. Does end tidal CO2 monitoring during emergency department procedural sedation and analgesia with propofol decrease the incidence of hypoxic events? A randomized, controlled trial. Ann Emerg Med 2010; 55:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/62\">",
"      Qadeer MA, Vargo JJ, Dumot JA, et al. Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangiopancreatography and ultrasonography. Gastroenterology 2009; 136:1568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/63\">",
"      Fearon DM, Steele DW. End-tidal carbon dioxide predicts the presence and severity of acidosis in children with diabetes. Acad Emerg Med 2002; 9:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/64\">",
"      Garcia E, Abramo TJ, Okada P, et al. Capnometry for noninvasive continuous monitoring of metabolic status in pediatric diabetic ketoacidosis. Crit Care Med 2003; 31:2539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44328/abstract/65\">",
"      Nagler J, Wright RO, Krauss B. End-tidal carbon dioxide as a measure of acidosis among children with gastroenteritis. Pediatrics 2006; 118:260.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 273 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-122.72.80.101-2F8DE301F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44328=[""].join("\n");
var outline_f43_18_44328=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PRINCIPLES OF OPERATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CO2 WAVEFORM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL APPLICATIONS FOR INTUBATED PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Verification of ETT placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Monitoring ETT location during transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Effectiveness of CPR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Return of spontaneous circulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Prognosis in cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cause of cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Increased ICP and trauma prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL APPLICATIONS FOR SPONTANEOUSLY BREATHING PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Critical illness and seizure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Acute respiratory distress",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Procedural sedation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Ventilation in obtunded or unconscious patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Detecting metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      LIMITATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DISCLOSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/273\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/273|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?0/54/879\" title=\"algorithm 1A\">",
"      ETT confirm colorimetry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?2/2/2095\" title=\"algorithm 1B\">",
"      ETT confirm capnography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/273|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/19/25917\" title=\"figure 1\">",
"      Normal CO2 waveform",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/25/12701\" title=\"figure 2\">",
"      CO2 waveform COPD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/48/34563\" title=\"figure 3A\">",
"      EtCO2 wave interpretation a",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?29/45/30420\" title=\"figure 3B\">",
"      EtCO2 wave interpretation b",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/273|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/63/15351\" title=\"picture 1\">",
"      EtCO2 monitor photo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/273|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/8/138\" title=\"table 1\">",
"      Capnography for management chemical terrorism agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/52/5963\" title=\"table 2\">",
"      CO2 waveform diagnostics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/25/36248?source=related_link\">",
"      Basic life support (BLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=related_link\">",
"      Procedural sedation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_18_44329="Specific learning disabilities in children: Role of the primary care provider";
var content_f43_18_44329=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Specific learning disabilities in children: Role of the primary care provider",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/18/44329/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44329/contributors\">",
"     L. Erik von Hahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/18/44329/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44329/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44329/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/18/44329/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/18/44329/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/18/44329/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H546788236\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine supervision of a child&rsquo;s educational status, including advocacy to assure the child&rsquo;s access to quality educational practices, is an important component of health supervision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/1\">",
"     1",
"    </a>",
"    ]. Educational status has significant effects on long-term health [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/2\">",
"     2",
"    </a>",
"    ]. Factors that are associated with positive health outcomes include attending a high-quality preschool, social-emotional status in elementary school, and completion of high school [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/3\">",
"     3",
"    </a>",
"    ]. Early intervention programs, offered before the age of five years, appear to be particularly important predictors of future health status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/4\">",
"     4",
"    </a>",
"    ]. For these reasons, routine supervision of a child&rsquo;s education is an important component of well-child care.",
"   </p>",
"   <p>",
"    The role of the primary care provider in the evaluation and management of learning disabilities (LD) in children will be discussed here. The clinical features, evaluation, and management of LD in the educational system, and laws pertaining to specific learning disabilities in the United States, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32665?source=see_link\">",
"     \"Specific learning disabilities in children: Clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link\">",
"     \"Specific learning disabilities in children: Evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37306?source=see_link\">",
"     \"Specific learning disabilities in children: Educational management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=see_link\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H546788268\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation and management of learning disabilities (LD) requires input from multiple clinicians, including the primary care provider. The primary responsibilities of the primary care provider are to assist in the diagnosis and management of LD and its co-occurring conditions and to provide case management under a medical home model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H629395108\">",
"     'Early identification'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/5/27737?source=see_link&amp;anchor=H16#H16\">",
"     \"Children with special health care needs\", section on 'Medical home'",
"    </a>",
"    .) Secondary roles include serving as a resource to families about community services, advocating for the child&rsquo;s rights and needs at school, serving as a mediator between the family and the school team, and serving as a consultant and resource to the school team.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary roles &ndash; The diagnosis of learning disability (LD) usually is made by educators, psychologists,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      developmental-behavioral pediatricians. Nonetheless, the primary care provider's expertise and unique clinical perspective play a vital role in the identification and evaluation of children with LD. A primary role of the pediatric clinician is to help identify the student who may need special education services, to complete a medical evaluation (eg, to exclude attention deficit hyperactivity disorder, sleep problems, seizures), to discuss reasons for learning failure with the family, and to provide information about LD and its co-occurring conditions. (See",
"      <a class=\"local\" href=\"#H629395108\">",
"       'Early identification'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H546787491\">",
"       'Education and counseling'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Primary care providers who have a longstanding relationship with the child and family may be better able to help the family articulate their concerns than educators or clinicians with whom the family is less familiar, thus helping to identify students who may have LD. Primary care providers also may have information that can facilitate the school team's understanding of the child's learning needs (eg, knowledge of psychosocial, cultural, medical, or environmental factors that affect the child's ability to learn) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/5\">",
"       5",
"      </a>",
"      ]. In addition, the primary care provider can assist the parents with the interpretation of school evaluations and in negotiating the special education system [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/6\">",
"       6",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H973828\">",
"       'Advocacy and support'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Finally, the pediatric clinician can help the family understand LD and its co-occurring conditions so that they can seek appropriate services. (See",
"      <a class=\"local\" href=\"#H629397303\">",
"       'Care coordination'",
"      </a>",
"      below.) In these capacities, the primary care provider can serve an important role for children with LD.",
"     </li>",
"     <li>",
"      Secondary roles &ndash; The primary care provider can also play a number of secondary roles in the management of children with disabilities who receive special services at school. These include providing information about",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      referrals to community agencies that provide treatment for the disability and its co-occurring conditions; serving as an advocate for the child vis-&agrave;-vis the school and other community agencies; serving as a mediator between the family and the school team when there are disagreements; and assisting the school team in the delivery of services. (See",
"      <a class=\"local\" href=\"#H972709\">",
"       'Communicating with the school team'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H546787514\">",
"       'Mediator'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629395108\">",
"    <span class=\"h1\">",
"     EARLY IDENTIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early identification of learning disabilities (LD) is crucial to providing appropriate interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Because early recognition may affect ultimate outcome, pediatric health care providers should have a low threshold for considering LD in children who are at risk for LD and children who have problems at school (whether the problems are in academic achievement, behavior, attention, or social interaction). The primary care provider can play a critical role when the child's learning problems are overlooked by the family",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    school personnel. LD should be considered if:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is parental concern about any school-related problem (eg, behavioral regulation, poor peer interactions, or learning problems)",
"     </li>",
"     <li>",
"      There is a family history of learning problems",
"     </li>",
"     <li>",
"      The child has a",
"      <span class=\"nowrap\">",
"       behavioral/mental",
"      </span>",
"      health condition",
"     </li>",
"     <li>",
"      The child has a history of developmental delay",
"     </li>",
"     <li>",
"      The child has a neurologic or genetic condition or history of central nervous system insult (seizure disorders, neurofibromatosis, tuberous sclerosis complex)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32665?source=see_link&amp;anchor=H6#H6\">",
"     \"Specific learning disabilities in children: Clinical features\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629395580\">",
"    <span class=\"h1\">",
"     MEDICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical evaluation should include a complete history and physical examination. The goal of the evaluation is to identify potential medical, neurologic,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    behavioral conditions that may be related to the learning disability (LD) or that may co-occur with the LD. The primary care provider often is already aware of co-occurring behavioral, neurologic, or genetic conditions related to learning failure. If such conditions are present, it is particularly important to ask about learning and school problems during regularly scheduled well-child visits. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/1,9\">",
"     1,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629395587\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The educational and learning histories are the most important aspects of the medical evaluation, particularly if the child has been followed consistently by the primary care provider and the provider is familiar with the child's medical conditions.",
"   </p>",
"   <p>",
"    The chief complaint of the parent or child usually suggests the problem area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/10\">",
"     10",
"    </a>",
"    ]. The health care provider should use standard descriptors to further define the type of learning problem (eg, the time that the learning problem was first identified, any improvement or worsening of the problem over time, factors that improved or aggravated the learning problem, etc). Students with learning problems often have impairments in more than one area, including vision, hearing, motor skills, attention and task completion skills, language skills, and social skills. The pediatric clinician should ask about problems in these areas, in addition to asking about problems in formal learning at school.",
"   </p>",
"   <p>",
"    The child's performance at school can be measured by report cards, teacher comments, parent observations, and history of academic progress over time. It is important to assure that the child has attended school regularly when making an assessment for LD. The likelihood of LD increases if learning failure is associated with certain medical, developmental, and familial factors (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32665?source=see_link&amp;anchor=H6#H6\">",
"     \"Specific learning disabilities in children: Clinical features\", section on 'Risk factors'",
"    </a>",
"    ). Consideration of these factors also informs the treatment plan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/1,9,10\">",
"     1,9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Important aspects of the history for a child in whom LD is being considered are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef76081 \" href=\"mobipreview.htm?25/48/26382\">",
"     table 1",
"    </a>",
"    ). The examiner should ask about the age of attainment of various developmental milestones, particularly language milestones (",
"    <a class=\"graphic graphic_table graphicRef60900 graphicRef69590 \" href=\"mobipreview.htm?33/59/34745\">",
"     table 2A-B",
"    </a>",
"    ). Past developmental delays can be associated with current learning problems.",
"   </p>",
"   <p>",
"    The child's abilities and strengths should be identified, as well as",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    disabilities. One way to access this information is to ask what activities the child enjoys doing or believes",
"    <span class=\"nowrap\">",
"     him/herself",
"    </span>",
"    to be good at doing. The child's interests and skills are useful in the development of a treatment plan. In the author&rsquo;s clinic, a detailed questionnaire about the student's school performance helps to complete the history when filled out by the classroom teacher (available from",
"    <a class=\"external\" href=\"file://www.floatinghospital.org/OurServices/CCSNDevelopmentalBehavioralPediatrics/OnlineForms\">",
"     the Floating Hospital for Children Center for Children with Special Needs",
"    </a>",
"    ). Rating scales such as the Conners&rsquo; rating scale [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/11\">",
"     11",
"    </a>",
"    ], Childhood Behavior Checklist (CBCL) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/12\">",
"     12",
"    </a>",
"    ], and Behavioral Assessment System for Children (BASC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/13,14\">",
"     13,14",
"    </a>",
"    ] include pertinent questions about the child&rsquo;s behaviors in the classroom, and are also a useful source of information about the student&rsquo;s classroom performance when completed by the classroom teacher. The Vanderbilt questionnaire for attention deficit hyperactivity disorder is available in the public domain (",
"    <a class=\"external\" href=\"file://www.brightfutures.org/\">",
"     www.brightfutures.org",
"    </a>",
"    ). It includes questions about classroom performance and co-occurring conditions, and can also be useful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629395594\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination of most children with LD is normal. Abnormalities on physical examination may suggest a particular neurologic or genetic condition that is associated with learning problems (eg, neurofibromatosis, tuberous sclerosis complex). However, children with these conditions typically do not present with learning failure as the first sign or symptom. Important aspects of the physical examination of a child in whom LD is a consideration are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef53481 \" href=\"mobipreview.htm?12/26/12717\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Dysmorphic features (ie, major or minor malformations) may suggest a genetic or congenital condition that is associated with learning problems (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/45/19161?source=see_link&amp;anchor=H4#H4\">",
"     \"Approach to congenital malformations\", section on 'Malformations'",
"    </a>",
"    ). The incidence of minor malformations is increased among children with LD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/15\">",
"     15",
"    </a>",
"    ]. However, no specific pattern of minor anomalies is pathognomonic for LD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The child's participation in the history-taking and the physical examination provides an opportunity to review his or her capacity to follow instructions and to use language to answer questions and participate in a conversation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629395601\">",
"    <span class=\"h2\">",
"     Informal testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pediatric health care provider can perform informal testing to review developmental functions (",
"    <a class=\"graphic graphic_table graphicRef60900 graphicRef69590 \" href=\"mobipreview.htm?33/59/34745\">",
"     table 2A-B",
"    </a>",
"    ) and to identify specific areas for further testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/17\">",
"     17",
"    </a>",
"    ]. Participation in structured developmental tasks can help the pediatric health care provider look more closely at the child's:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Capacity to focus attention",
"     </li>",
"     <li>",
"      Language and memory function (ability to understand, remember, and carry out instructions)",
"     </li>",
"     <li>",
"      Expressive language skills (ability to use vocabulary and grammar correctly)",
"     </li>",
"     <li>",
"      Pragmatic language skills (ability to carry on a conversation or tell a",
"      <span class=\"nowrap\">",
"       story/narrative)",
"      </span>",
"     </li>",
"     <li>",
"      Coordination skills",
"     </li>",
"     <li>",
"      Specific tasks of reading, writing, or math",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The pediatric health provider can incorporate some routine questions about language, phonologic, and reading skills during office encounters with young children to assess language and literacy skills (",
"    <a class=\"graphic graphic_table graphicRef69787 \" href=\"mobipreview.htm?16/36/16972\">",
"     table 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preschool and kindergarten children should be able to identify and provide words that rhyme (\"Tell me what rhymes with 'mat.'\")",
"     </li>",
"     <li>",
"      Kindergarten children should be able to identify letters and some of their sounds.",
"     </li>",
"     <li>",
"      Grade one children should be able to delete the beginning sound of a word (\"Say 'fireman' without saying 'man.\", \"If you take away the 'h' sound from 'hat,' what do you get?\") and replace the beginning sound of a word with a new letter (\"If you take the 't' sound in 'take' and replace it with a 'm,' what do you get?\")",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Failure to correctly answer questions such as these can signal phonologic weaknesses and potential reading disorders. At all ages, difficulty pronouncing basic sounds, mispronunciation of long or complicated words, halting speech, laborious and slow reading or writing, poor spelling,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the need for extra time in reading",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to take tests are important indicators of a potential reading disorder (",
"    <a class=\"graphic graphic_table graphicRef54976 \" href=\"mobipreview.htm?25/18/25901\">",
"     table 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef82083 \" href=\"mobipreview.htm?41/31/42492\">",
"     table 6",
"    </a>",
"    ). Although additional evaluation is necessary, the primary care provider should have a high suspicion for a reading disorder and a low threshold for referral. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/21/1370?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical features and evaluation of reading difficulty in children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Testing can also help in assessing basic knowledge and mental status. A formal battery of psychoeducational tests is usually administered by a psychologist or educator, but some primary care providers may use developmental assessment tools to add to the information that they have gathered. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link&amp;anchor=H22#H22\">",
"     \"Specific learning disabilities in children: Evaluation\", section on 'Psychometric tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629395608\">",
"    <span class=\"h2\">",
"     Ancillary medical testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific laboratory tests that are especially important or useful in the evaluation of LD unless indicated by the medical history",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    physical examination. However, it is crucial to assure normal hearing and vision. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/13/43225?source=see_link&amp;anchor=H9#H9\">",
"     \"Screening tests in children and adolescents\", section on 'Hearing screen'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/13/43225?source=see_link&amp;anchor=H12#H12\">",
"     \"Screening tests in children and adolescents\", section on 'Vision screen'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H546788260\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary care provider may play several roles in the management of learning disabilities (LD) in children. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assisting in the evaluation of LD and co-occurring conditions (see",
"      <a class=\"local\" href=\"#H629395108\">",
"       'Early identification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H629395580\">",
"       'Medical evaluation'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      After the comprehensive evaluation for LD, explaining the nature of the child&rsquo;s disability and any co-occurring conditions to the caregivers and patient (if developmentally appropriate) (see",
"      <a class=\"local\" href=\"#H546787491\">",
"       'Education and counseling'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Providing information about the legal rights of the child under No Child Left Behind (NCLB), Section 504 of the Rehabilitation act (",
"      <a class=\"graphic graphic_table graphicRef68063 \" href=\"mobipreview.htm?11/20/11597\">",
"       table 7",
"      </a>",
"      ), and the Individuals with Disabilities Education Act (IDEA) (see",
"      <a class=\"local\" href=\"#H973828\">",
"       'Advocacy and support'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=see_link&amp;anchor=H4#H4\">",
"       \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Laws affecting the education of students with disabilities'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Coordinating care under a medical home model and providing treatment for co-occurring conditions, including medication management when appropriate (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/5/27737?source=see_link&amp;anchor=H16#H16\">",
"       \"Children with special health care needs\", section on 'Medical home'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Advocating on behalf of the family when they are unable to do so on their own",
"     </li>",
"     <li>",
"      Mediating between the family and the school team (see",
"      <a class=\"local\" href=\"#H546787514\">",
"       'Mediator'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Serving as a consultant and information resource for the school team (see",
"      <a class=\"local\" href=\"#H972709\">",
"       'Communicating with the school team'",
"      </a>",
"      below) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H546787491\">",
"    <span class=\"h2\">",
"     Education and counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Information that the pediatric clinician should share is listed in the paragraphs that follow and includes education and counseling about:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Learning disabilities",
"     </li>",
"     <li>",
"      Nonstandard therapies",
"     </li>",
"     <li>",
"      Psychosocial management",
"     </li>",
"     <li>",
"      Legal rights",
"     </li>",
"     <li>",
"      Resources",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629397583\">",
"    <span class=\"h3\">",
"     Learning disabilities",
"    </span>",
"    &nbsp;&mdash;&nbsp;After a child is diagnosed with an LD, the primary care provider can provide information about the nature of LD and its management.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Interpretation of evaluation reports (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link&amp;anchor=H23#H23\">",
"       \"Specific learning disabilities in children: Evaluation\", section on 'Formulas used to identify LD'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      A description of the specific skills that may be delayed and that should be the focus of intervention in LD (eg, phoneme awareness and phonics; reading comprehension; spelling instruction; number sense; organizational skills, etc) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32665?source=see_link&amp;anchor=H8#H8\">",
"       \"Specific learning disabilities in children: Clinical features\", section on 'Clinical features'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32665?source=see_link&amp;anchor=H9#H9\">",
"       \"Specific learning disabilities in children: Clinical features\", section on 'LD syndromes'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      A description of the types of treatments and accommodations required by students with LD (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37306?source=see_link&amp;anchor=H11284731#H11284731\">",
"       \"Specific learning disabilities in children: Educational management\", section on 'Quality instruction for LD'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Information about the developmental and mental health conditions that frequently co-occur with LD (eg, language disorder, attention deficit hyperactivity disorder (ADHD), behavior disorders, anxiety, depression) and counseling about the social isolation that can sometimes occur as a result of LD and its co-occurring conditions (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32665?source=see_link&amp;anchor=H18#H18\">",
"       \"Specific learning disabilities in children: Clinical features\", section on 'Comorbidities'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H288991785\">",
"    <span class=\"h3\">",
"     Nonstandard therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parents of children with learning disability (LD) may learn about new therapies or management strategies from popular books, newspapers, magazines, the Internet, or broadcast media [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/18\">",
"     18",
"    </a>",
"    ]. Parents should be encouraged to consult educational experts regarding unproven therapies, since these therapies may lack the support of research data and may be proposed to the public before they are replicated and evaluated using valid scientific methods [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/10,19\">",
"     10,19",
"    </a>",
"    ]. Nonstandard therapies for LD include neurologic training to correct or retrain sensory pathways and include patterning, optometric visual training, treatment of cerebellar-vestibular dysfunction, applied kinesiology, and colored overlays or lenses (Irlen overlays or lenses) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/18-22\">",
"     18-22",
"    </a>",
"    ]. There is no evidence to support the use of these therapies in the treatment of LD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/23-30\">",
"     23-30",
"    </a>",
"    ]. Other nonproven, nonstandard therapies include the elimination of food dyes, the use of megavitamins, the supplementation of trace mineral elements, and a diet to treat hypoglycemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26836570\">",
"    <span class=\"h3\">",
"     Psychosocial management",
"    </span>",
"    &nbsp;&mdash;&nbsp;In conjunction with instructional methods to increase academic skills, children with LD may benefit from support or psychologic counseling, behavior modification, and social-skills training to reduce the primary or secondary emotional and behavioral problems that are associated with LD (eg, anxiety, withdrawal, depression, conduct disorders) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/8,10,19,31\">",
"     8,10,19,31",
"    </a>",
"    ]. The family can also play an important positive role in the adjustment to and management of LD.",
"   </p>",
"   <p>",
"    Psychologic counseling may be useful for the following situations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Repair of the child&rsquo;s self-esteem",
"     </li>",
"     <li>",
"      Development of behavioral goals and the management of behavior",
"     </li>",
"     <li>",
"      Restoration of self-regulation or discipline at home and at school",
"     </li>",
"     <li>",
"      Restoration of a significant adult-child relationship",
"     </li>",
"     <li>",
"      Support of the child or family through a crisis situation",
"     </li>",
"     <li>",
"      Treatment of comorbid secondary anxiety, depression, etc",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The self-esteem and social skills of children with LD can be enhanced through participation in activities outside of school, particularly activities in which the child or adolescent can excel (eg, sports, music, drama, arts and crafts) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/8,10,19,32\">",
"     8,10,19,32",
"    </a>",
"    ]. Children who are reluctant to participate in team sports may benefit from independent activities, such as martial arts, swimming, diving, horseback riding, skiing, bowling, or track and field. Children with LD also may experience a sense of accomplishment through the completion of assigned responsibilities at school or home. The tasks that are chosen should be ones that the child is likely to perform successfully [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The attitudes, behaviors, and emotional support provided by the family of an individual with LD influence the resiliency and success of the individual [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. Characteristics such as the ability to plan the steps required to achieve a goal (executive functions) and a sense of self-efficacy enable the child or adolescent to generate positive responses from themselves and from others, which can help overcome the frustration of learning tasks that are difficult for them. The presence of supportive adults, in addition to a child's parents (eg, grandparents, mentors, coaches, members of a church group) and the existence of appropriate opportunities at major life transitions, also helps students with LD cope with their disability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/35\">",
"     35",
"    </a>",
"    ]. Parents, siblings, and other caregivers affect the development of self-esteem and self-efficacy through their attitudes and behaviors. Strategies that encourage the development of resiliency among children and adolescents with LD are outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef72848 \" href=\"mobipreview.htm?28/42/29357\">",
"     table 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629397598\">",
"    <span class=\"h3\">",
"     Legal rights",
"    </span>",
"    &nbsp;&mdash;&nbsp;Families of children with LD may ask the primary care provider to provide information about their child&rsquo;s legal rights in the school setting. They may obtain this information from other sources, such as regional technical assistance centers, one or more of which is available in each state (see Technical Assistance Alliance for Parent Centers (",
"    <a class=\"external\" href=\"file://www.taalliance.org/\">",
"     www.taalliance.org",
"    </a>",
"    )); the Council for Exceptional Children, a national organization; or from other agencies (",
"    <a class=\"graphic graphic_table graphicRef57599 \" href=\"mobipreview.htm?35/4/35917\">",
"     table 9",
"    </a>",
"    ). However, families do not always know how to interpret or use the information that they obtain, and may turn to the primary care provider for guidance.",
"   </p>",
"   <p>",
"    The primary care provider can provide counseling to the family about the rights offered under No Child Left Behind (NCLB), the Individuals with Disability Education Act (IDEA), and Section 504 of the Rehabilitation Act (",
"    <a class=\"graphic graphic_table graphicRef68063 \" href=\"mobipreview.htm?11/20/11597\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Most students with disabilities have rights under either the IDEA or under Section 504 of the Rehabilitation act (which is subsumed under the Americans with Disabilities Act [ADA] (",
"    <a class=\"graphic graphic_table graphicRef80545 \" href=\"mobipreview.htm?3/19/3389\">",
"     table 10",
"    </a>",
"    )), as long as they meet the functional impairment criteria set out by these laws. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=see_link&amp;anchor=H4#H4\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Laws affecting the education of students with disabilities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Schools are often criticized for not doing enough for students with disabilities, regardless of their legal obligations. Parents often perceive that schools withhold services because of funding concerns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/39\">",
"     39",
"    </a>",
"    ]. This can be true, as the IDEA is an underfunded mandate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/40\">",
"     40",
"    </a>",
"    ], and the ADA is not associated with any special funding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/41\">",
"     41",
"    </a>",
"    ], information that is useful to share with families. However, the majority of parents are satisfied with their child&rsquo;s special education services at school [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/39\">",
"     39",
"    </a>",
"    ]. Whether or not the student has a documented disability, his or her success depends primarily on the receipt of quality instruction and does not always depend directly on the financial resources of the school district. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37306?source=see_link&amp;anchor=H11284731#H11284731\">",
"     \"Specific learning disabilities in children: Educational management\", section on 'Quality instruction for LD'",
"    </a>",
"    .) Helping a family collaborate and work creatively toward common goals with the school team can be a major role for the primary care provider.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H973143\">",
"    <span class=\"h3\">",
"     Resources",
"    </span>",
"    &nbsp;&mdash;&nbsp;A list of resources for health care providers, patients, and families of children with LD is provided in the table (",
"    <a class=\"graphic graphic_table graphicRef57599 \" href=\"mobipreview.htm?35/4/35917\">",
"     table 9",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Pediatric clinicians are encouraged to review CPT (Current Procedural Terminology) codes in their state to determine how the cost of consultation time with families can be recuperated. In the author&rsquo;s clinic, visits that are focused on counseling and the education of the family are billed using office visit codes, indicating the duration (number of minutes) of the encounter. The clinic notes document that counseling was provided to the family &ldquo;for greater than 50 percent of the total time spent with the family.&rdquo;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629397303\">",
"    <span class=\"h2\">",
"     Care coordination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Care coordination is one of the primary responsibilities of the primary care provider for the child with LD. Children with LD may require referral for evaluation and treatment of genetic, neurologic,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mental health conditions and oversight of the treatment of such conditions.",
"   </p>",
"   <p>",
"    In the role of care coordinator, the primary care provider also may make referrals to community agencies that provide supplementary instruction, training in behavioral regulation, opportunities to build social skills, support for the parents, etc. Sample resources and agencies to which families can be referred are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef57599 \" href=\"mobipreview.htm?35/4/35917\">",
"     table 9",
"    </a>",
"    ). In addition, the pediatric clinician should refer to local mental health agencies",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to a developmental pediatrician, child neurologist, or child psychiatrist who is familiar with the needs of students with LD when the explanation for learning failure is unclear, or for the management of co-occurring conditions.",
"   </p>",
"   <p>",
"    Pediatric clinicians are encouraged to review CPT (Current Procedural Terminology) codes in their state to determine how the cost of care coordination can be recuperated. The AAP offers guidance on the use of CPT care coordination codes, though the time spent on care coordination may not be reimbursed consistently (",
"    <a class=\"external\" href=\"file://www.aap.org\">",
"     www.aap.org",
"    </a>",
"    , Practice Management Online).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H973828\">",
"    <span class=\"h2\">",
"     Advocacy and support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parents may find it difficult to advocate for their child when they are new to the role of advocate, unfamiliar with the diagnosis of LD or their child&rsquo;s legal rights, or when they have a disability themselves (eg, language disability, learning disability, mental health condition). The primary care provider can provide advocacy and support for children and families of children with learning difficulty by:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Helping them to organize their thoughts before communicating with the school team or by speaking to the school team on their behalf. Examples include: helping the family to organize their questions and requests before an individualized education program (IEP) meeting; communicating the family&rsquo;s concerns on their behalf during a telephone conversation with the school team; attending an IEP meeting with the family or suggesting that a family friend, another family member, or a hired advocate attend the meeting with them. The author of this topic review sometimes uses the office encounter to conduct a telephone meeting with the school team with the family present.",
"     </li>",
"     <li>",
"      Providing information about the child's behavioral and medical needs to the school team. (See",
"      <a class=\"local\" href=\"#H972709\">",
"       'Communicating with the school team'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Helping them understand education law. (See",
"      <a class=\"local\" href=\"#H629397598\">",
"       'Legal rights'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=see_link&amp;anchor=H4#H4\">",
"       \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Laws affecting the education of students with disabilities'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Advocating for services when the primary care provider believes they are needed and were not offered by the school team. (See",
"      <a class=\"local\" href=\"#H546787514\">",
"       'Mediator'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Helping the family to understand why the school team may have decided not to provide services when the family believes the child is in need of services. (See",
"      <a class=\"local\" href=\"#H546787491\">",
"       'Education and counseling'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H546787542\">",
"       'Service delivery decisions: PCP's role'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To be a successful advocate, the primary care provider must [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/42\">",
"     42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Have a working knowledge of psychometric measures and their interpretation (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link&amp;anchor=H22#H22\">",
"       \"Specific learning disabilities in children: Evaluation\", section on 'Psychometric tests'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link&amp;anchor=H23#H23\">",
"       \"Specific learning disabilities in children: Evaluation\", section on 'Formulas used to identify LD'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Understand the varying ways in which special education teams make decisions regarding eligibility for special education (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link&amp;anchor=H25#H25\">",
"       \"Specific learning disabilities in children: Evaluation\", section on 'Determination of service eligibility'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Understand the limitations of service obligations of schools under education law (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=see_link&amp;anchor=H18#H18\">",
"       \"Specific learning disabilities in children: Evaluation\", section on 'Evaluation and identification of LD in school settings'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=see_link&amp;anchor=H4#H4\">",
"       \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Laws affecting the education of students with disabilities'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At the community level, the primary care provider may advocate for children with learning disabilities by becoming a member of the school committee or collaborating with school administrators to assure systems that identify and serve children with disabilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H546787514\">",
"    <span class=\"h2\">",
"     Mediator",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric health care providers may take on the role of mediator when a family is in disagreement with the school team about the provision of services for their child and asks the provider for advice. In such situations, the primary care provider can start by determining whether the family has a correct understanding of their legal rights and whether the school team has fulfilled the procedural safeguards required by law (eg, under the IDEA, an evaluation has to be conducted upon parent request and completed within 60 days, etc) (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=see_link&amp;anchor=H4#H4\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Laws affecting the education of students with disabilities'",
"    </a>",
"    ). Next, it is important to understand the family&rsquo;s disagreement and why they believe that a service for their child is needed. Following this, it is often helpful to call a member of the child&rsquo;s school team, such as the special education coordinator or the school principal, to learn about why the conflict may have arisen. The pediatric clinician is not likely to understand the context of the disagreement without a call to the school. Sometimes, sharing perspectives between the family and the school team is sufficient to help each party see &ldquo;eye to eye.&rdquo; At other times, when the family has a valid reason for disagreement, they may need to be referred to advocacy services or other clinicians who may be more experienced in managing situations of conflict, such as a developmental behavioral pediatrician, a child psychologist or psychiatrist who is familiar with the needs of children who require special education services, or a regional technical assistance center (",
"    <a class=\"external\" href=\"file://www.taalliance.org/\">",
"     www.taalliance.org",
"    </a>",
"    ) (",
"    <a class=\"graphic graphic_table graphicRef57599 \" href=\"mobipreview.htm?35/4/35917\">",
"     table 9",
"    </a>",
"    ). The family can also seek redress through mediation or by due process hearings through the state board of education.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H972709\">",
"    <span class=\"h2\">",
"     Communicating with the school team",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many pediatric clinicians are interested in participating in school health programming, which includes providing for the physical and mental health needs of students [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/43\">",
"     43",
"    </a>",
"    ]. Pediatric clinicians have much to offer to school professionals and can help improve services for students when they communicate effectively. School teams typically value the input of physicians and other medical personnel. However, they can also experience significant frustration in their interactions with medical personnel, specifically when medical personnel do not communicate with schools [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/44\">",
"     44",
"    </a>",
"    ]. One of the major reasons that schools hire a pediatric consultant is to assure effective communication between the school team and the child&rsquo;s health care provider [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/45\">",
"     45",
"    </a>",
"    ]. This speaks to the importance of communication that occurs directly between pediatric clinicians and the child&rsquo;s school team members.",
"   </p>",
"   <p>",
"    All communication between the primary care provider and members of the school team should occur with the knowledge and agreement of the family. The child psychiatry literature offers guidelines and suggestions for how to consult with school teams, which can help inform how the primary care provider should consult with school teams [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Effective communication with school teams improves with practice, and over time.",
"   </p>",
"   <p>",
"    When communicating with schools, personally or in writing, it is important for the primary care provider to understand the type of information most needed by schools; the legal weight of recommendations provided by a pediatric clinician when the school makes service delivery decisions; and the circumscribed nature of therapeutic services in school settings. These aspects of communication are described in the following sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H972939\">",
"    <span class=\"h3\">",
"     Useful information",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      About medical conditions &ndash; The type of information that is most useful to schools concerns diagnoses that they are not able to make on their own (eg, medical or mental health conditions, such as epilepsy, attention deficit disorder, autism, etc), and information about the effects of the condition(s)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      its treatment(s) on the child&rsquo;s ability to learn. A major concern for many school professionals is the wish to avoid harming the student, either through action or inaction related to the student&rsquo;s medical or mental health conditions. The pediatric clinician can help address these concerns, but personal communication with the school team may be required to assure that the correct questions are answered.",
"     </li>",
"     <li>",
"      About prescriptions &ndash; The school team may require explicit or prescriptive information from the pediatric clinician. This typically applies to the administration of medications or other medical interventions at school, rather than prescriptions for rehabilitative services (see",
"      <a class=\"local\" href=\"#H546787549\">",
"       'Services at school: Educational versus rehabilitative'",
"      </a>",
"      below). To assure that medications or other interventions are administered or used appropriately, personal communication with the school nurse may be required. Subspecialists may need to provide information for certain interventions (eg, orthotic devices, ventilators, etc). Specific guidelines about the use of medications in schools are available from the American Academy of Pediatrics [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/48\">",
"       48",
"      </a>",
"      ]. Of note, the Individuals with Disabilities Education Act specifically prohibits any requirement that parents seek the use of medications before evaluations or services are provided [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      About the student&rsquo;s capacity to participate at school &ndash; The school team may require information about potential effects of the student&rsquo;s medical condition(s) or treatment(s) on the student&rsquo;s performance in the classroom or other school-related activities. This information may need to be very explicit in order for the student to receive the necessary evaluations",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      services. It may include comments about the student&rsquo;s capacity to navigate the school environment; capacity to remain seated for the duration of the school day; capacity to follow school rules and classroom routines; ability to participate in classroom discussions; capacity to focus; capacity for peer relations; ability to complete classroom work and homework, etc. Pediatric health care providers are not necessarily trained to think about the functional or educational needs of students in school settings and may not be certain about how to describe the functional impact of the child&rsquo;s condition on his or her performance at school or to make recommendations that reflect all of the student&rsquo;s needs. In such situations, it is best for the pediatric clinician to speak directly with classroom staff, and then make an estimate about how the student&rsquo;s medical or behavioral conditions might be related to classroom performance. A convenient way to obtain this information is to have the classroom teacher describe his or her concerns about the student&rsquo;s performance in class, or to complete a questionnaire about school function. The questionnaire used in the author&rsquo;s clinic is available from",
"      <a class=\"external\" href=\"file://www.floatinghospital.org/OurServices/CCSNDevelopmentalBehavioralPediatrics/OnlineForms\">",
"       the Floating Hospital for Children Center for Children with Special Needs",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      About testing or services needed &ndash; Based on the information gathered about the student, the pediatric clinician can make recommendations for testing (eg, screening evaluation for mental health conditions,",
"      <span class=\"nowrap\">",
"       speech/language",
"      </span>",
"      testing, occupational therapy testing, etc) or make recommendations for specific kinds of services (eg, behavior management, counseling, instruction in social interactions, etc).",
"      <br/>",
"      <br/>",
"      In order to maximize the chances that recommendations made by a pediatric clinician will be considered thoughtfully by the school team, the pediatric clinician must have information about the child&rsquo;s performance at school, either in the form of a questionnaire about school performance (eg, the school questionnaire available from",
"      <a class=\"external\" href=\"file://www.floatinghospital.org/OurServices/CCSNDevelopmentalBehavioralPediatrics/OnlineForms\">",
"       the Floating Hospital for Children Center for Children with Special Needs",
"      </a>",
"      ) or by having a conversation with a member of the school team. Recommendations made by the pediatric clinician following a conversation with a school team member are more likely to reflect the student&rsquo;s actual needs and to be considered favorably by the school. When recommendations are provided in writing, the author typically includes a statement, such as, &ldquo;the following recommendations were discussed with the student&rsquo;s school team on [mention date],&rdquo; to show the reader of the document that the school team&rsquo;s perspective was considered before the recommendations were made. This type of thoughtfulness is highly valued by schools.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H972716\">",
"    <span class=\"h4\">",
"     Written documentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Families may ask the primary care provider to provide written documentation of their child&rsquo;s diagnosis (or diagnoses) or a &ldquo;prescription&rdquo; for education or related services at school. Requests for diagnostic information may be requested by the school as a routine, while requests for specific evaluations or services may be related to conflict between the family and the school about service delivery decisions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/50\">",
"     50",
"    </a>",
"    ]. Useful written documentation requires the pediatric clinician to understand the context in which the information is being requested.",
"   </p>",
"   <p>",
"    Sharing diagnostic information is typically a straightforward process. However, it is helpful if the primary care provider reminds the family that the presence of a disability does not guarantee the provision of services: it is the functional impairment of the disability that determines whether services are provided [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H546787542\">",
"     'Service delivery decisions: PCP's role'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    When specific recommendations for testing or services are sought by the family, the pediatric clinician can call the school to find out why the recommendations are being sought, and to find out what information or recommendations would be most useful to the school team. Failure to do so can reinforce conflicts between the family and the school [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/44\">",
"     44",
"    </a>",
"    ]. Sometimes, verbal communication obviates the need for written documentation, simply because the pediatric clinician has spoken on behalf of the family and has helped the school team to understand the family&rsquo;s needs or concerns. In most cases, written documentation from the pediatric clinician is more useful to the school team and received more positively when there has been a prior conversation with a member of the school team.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H546787542\">",
"    <span class=\"h3\">",
"     Service delivery decisions: PCP's role",
"    </span>",
"    &nbsp;&mdash;&nbsp;The law requires schools to make service delivery decisions collaboratively. This means that schools make decisions by &ldquo;considering&rdquo; (a legal term found in the IDEA) the input of outside providers (including the primary care provider), along with the input of school team members and the family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/52\">",
"     52",
"    </a>",
"    ]. No single clinician, teacher, or administrator is allowed to determine how services are to be delivered. This process, when conducted successfully, allows the school team to consider options for service delivery that are therapeutically and educationally sound, but that also are consistent with the school ecology and resources as a whole. That being said, service delivery decisions are sometimes made on the basis of the services available at the school, not on the basis of the services needed by the student. In such cases, input from the pediatric clinician that reveals an understanding of the student&rsquo;s needs at school can carry significant weight in service delivery decisions at school.",
"   </p>",
"   <p>",
"    Schools sometimes appear to make service delivery decisions contingent upon the pediatric clinician&rsquo;s input. Families and even school teams sometimes believe that the pediatric clinician&rsquo;s input is a requirement for the delivery of certain kinds of services at school (eg, specialized services for a student with a diagnosis of autism). However, neither Section 504 of the Rehabilitation Act nor the Individuals with Disability Education Act (IDEA) supports the practice of withholding services until a diagnosis is &ldquo;proven&rdquo; to exist. First, schools cannot require the family to use insurance benefits in order to obtain the information that the school needs to make service decisions, although they can request this information if the family is willing to share it and if the family has medical insurance. Second, although a handicapping condition is a prerequisite for the delivery of services under both Section 504 and the IDEA, it is the functional impairment that determines the services provided, not the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/51\">",
"     51",
"    </a>",
"    ]. Schools have great legal latitude in providing services to students who may need them. Education and disability rights laws include many provisions to assure successful service delivery to student without the input of any outside clinicians.",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H546787549\">",
"    <span class=\"h3\">",
"     Services at school: Educational versus rehabilitative",
"    </span>",
"    &nbsp;&mdash;&nbsp;Schools provide therapeutic services that are related to the student&rsquo;s education [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/6,42,53\">",
"     6,42,53",
"    </a>",
"    ]. They do not offer therapeutic services in a rehabilitative mode of care. Medical services and interventions that are offered in schools are circumscribed to assure that the student can receive a &ldquo;meaningful education&rdquo; from his or her individualized educational program under the Individuals with Disabilities Education Act [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/18/44329/abstract/54\">",
"     54",
"    </a>",
"    ],",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to prevent discrimination by providing equal access to an education program under the Americans with Disabilities Act (",
"    <a class=\"graphic graphic_table graphicRef80545 \" href=\"mobipreview.htm?3/19/3389\">",
"     table 10",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=see_link&amp;anchor=H4#H4\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Laws affecting the education of students with disabilities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, for example, physical therapy (PT) and occupational therapy (OT) services are provided to assure that the student can navigate successfully the school environment, remain seated and participate in classroom discussion, and complete any of the other fine or gross motor tasks required in the school setting. Similarly,",
"    <span class=\"nowrap\">",
"     speech/language",
"    </span>",
"    services are provided so that the student can participate in classroom discussions, complete reading and writing tasks, and interact with peers. Given the many tasks required by students in school, students often do receive services that provide rehabilitative benefits since the distinction between &ldquo;rehabilitative&rdquo; and &ldquo;educational&rdquo; is not always clear. However, the pediatric clinician should understand that rehabilitation is not the intent of education or civil rights laws. Some rehabilitative services can and should be accessed through the child&rsquo;s health insurance plan, allowing the child to focus on his or her education while in the school setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H629397728\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary responsibilities of the primary care provider in the care of the child with learning disability (LD) are to assist in the diagnosis and management of LD and its co-occurring conditions and to provide case management under a medical home model. (See",
"      <a class=\"local\" href=\"#H546788268\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early identification of LD is crucial to providing appropriate interventions. Pediatric health care providers should have a low threshold for considering LD in children who are at risk for LD and children who have problems at school. (See",
"      <a class=\"local\" href=\"#H629395108\">",
"       'Early identification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goal of the medical evaluation is to identify potential medical, neurologic,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      behavioral conditions that may be related to the LD or that may co-occur with the LD. Important aspects of the history and examination are provided in the tables (",
"      <a class=\"graphic graphic_table graphicRef76081 \" href=\"mobipreview.htm?25/48/26382\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef53481 \" href=\"mobipreview.htm?12/26/12717\">",
"       table 3",
"      </a>",
"      ). It is crucial to assure normal hearing and vision. (See",
"      <a class=\"local\" href=\"#H629395580\">",
"       'Medical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once a child has been diagnosed with a learning disability, the primary care provider should coordinate care and provide treatment for co-occurring conditions. (See",
"      <a class=\"local\" href=\"#H629397303\">",
"       'Care coordination'",
"      </a>",
"      above.) Additional roles may include: &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Provision of education and counseling about learning disabilities and the child&rsquo;s legal rights (",
"      <a class=\"graphic graphic_table graphicRef57599 \" href=\"mobipreview.htm?35/4/35917\">",
"       table 9",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H546787491\">",
"       'Education and counseling'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Advocacy and support for the child and family (see",
"      <a class=\"local\" href=\"#H973828\">",
"       'Advocacy and support'",
"      </a>",
"      above) &nbsp;",
"     </li>",
"     <li>",
"      Mediating between the family and the school team (see",
"      <a class=\"local\" href=\"#H546787514\">",
"       'Mediator'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Serving as a consultant and information resource for the school team (see",
"      <a class=\"local\" href=\"#H972709\">",
"       'Communicating with the school team'",
"      </a>",
"      above) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/1\">",
"      Bravender T. School performance: the pediatrician's role. Clin Pediatr (Phila) 2008; 47:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/2\">",
"      Schnittker J. Education and the changing shape of the income gradient in health. J Health Soc Behav 2004; 45:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/3\">",
"      Topitzes J, Godes O, Mersky JP, et al. Educational success and adult health: findings from the Chicago longitudinal study. Prev Sci 2009; 10:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/4\">",
"      Herrod HG. Do first years really last a lifetime? Clin Pediatr (Phila) 2007; 46:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/5\">",
"      Gresham F, MacMillan D, Bocian K. Agreement between school study team decisions and authoritative definitions in classification of students at-risk for mild disabilities. Sch Psychol Q 1998; 13:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/6\">",
"      Provision of educationally-related services for children and adolescents with chronic diseases and disabling conditions. American Academy of Pediatrics. Committee on Children with Disabilities. Pediatrics 2000; 105:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/7\">",
"      Lyon GR. Learning disabilities. Future Child 1996; 6:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/8\">",
"      Shapiro BK, Gallico RP. Learning disabilities. Pediatr Clin North Am 1993; 40:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/9\">",
"      Phillips DM, Longlett SK, Mulrine C, et al. School problems and the family physician. Am Fam Physician 1999; 59:2816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/10\">",
"      Silver LB. Psychological and family problems associated with learning disabilities: assessment and intervention. J Am Acad Child Adolesc Psychiatry 1989; 28:319.",
"     </a>",
"    </li>",
"    <li>",
"     Conners CK. Conners' Rating Scales - Revised User's Manual, Multi Health Systems, Inc, New York 1997.",
"    </li>",
"    <li>",
"     Reynolds, CR, Kamphaus, RW. Behavior Assessment System for Children - Manual, American Guidance Service, Inc., Ciricle Pine, MN 1992.",
"    </li>",
"    <li>",
"     Achenbach TM. Manual for the Child Behavior Checklist, University of Vermont, Department of Psychiatry, Burlington, VT 1991.",
"    </li>",
"    <li>",
"     Achenbach TM. Manual for the Teachers Report Form, University of Vermont, Department of Psychiatry, Burlington, VT 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/15\">",
"      Accardo PJ, Tomazic T, Morrow J, et al. Minor malformations, hyperactivity, and learning disabilities. Am J Dis Child 1991; 145:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/16\">",
"      Erenberg G. Learning disabilities: an overview. Semin Neurol 1991; 11:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/17\">",
"      Hagerman RJ. Pediatric assessment of the learning-disabled child. J Dev Behav Pediatr 1984; 5:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/18\">",
"      Silver LB. Nonstandard therapies of learning disabilities. Semin Neurol 1991; 11:57.",
"     </a>",
"    </li>",
"    <li>",
"     Silver LB. The Misunderstood Child: A Guide for Parents of Learning Disabled Children, McGraw-Hill, New York 1984.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/20\">",
"      McInerny TK. Children who have difficulty in school: a primary pediatrician's approach. Pediatr Rev 1995; 16:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/21\">",
"      Ziring PR, brazdziunas D, Cooley WC, et al. American Academy of Pediatrics. Committee on Children with Disabilities. The treatment of neurologically impaired children using patterning. Pediatrics 1999; 104:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/22\">",
"      Ritchie SJ, Della Sala S, McIntosh RD. Irlen colored overlays do not alleviate reading difficulties. Pediatrics 2011; 128:e932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/23\">",
"      American Academy of Pediatrics, Section on Ophthalmology, Council on Children with Disabilities, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Joint statement--Learning disabilities, dyslexia, and vision. Pediatrics 2009; 124:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/24\">",
"      Keogh BK, Pelland M. Vision training revisited. J Learn Disabil 1985; 18:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/25\">",
"      Beauchamp GR. Optometric vision training. Pediatrics 1986; 77:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/26\">",
"      Kavale K, Mattson PD. \"One jumped off the balance beam\": meta-analysis of perceptual-motor training. J Learn Disabil 1983; 16:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/27\">",
"      Solan HA. An appraisal of the Irlen technique of correcting reading disorders using tinted overlays and tinted lenses. J Learn Disabil 1990; 23:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/28\">",
"      Black JL, Collins DW, De Roach JN, Zubrick S. A detailed study of sequential saccadic eye movements for normal- and poor-reading children. Percept Mot Skills 1984; 59:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/29\">",
"      Sadun AA. Dyslexia at The New York Times: (mis)understanding of parallel visual processing. Arch Ophthalmol 1992; 110:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/30\">",
"      Handler SM, Fierson WM, Council on Children with Disabilities, et al. Learning disabilities, dyslexia, and vision. Pediatrics 2011; 127:e818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/31\">",
"      Fleischner JE. Educational management of students with learning disabilities. J Child Neurol 1995; 10 Suppl 1:S81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/32\">",
"      Lock RH, Janas M. Build Resiliency. Intervention in School &amp; Clinic 2002; 38:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/33\">",
"      Hermans H, van der Pas FH, Evenhuis HM. Instruments assessing anxiety in adults with intellectual disabilities: a systematic review. Res Dev Disabil 2011; 32:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/34\">",
"      Raskind MH, Gerber PJ, Goldberg RJ, et al. Longitudinal research in learning disabilities: report on an international symposium. J Learn Disabil 1998; 31:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/35\">",
"      Dole S. The implications of the risk and resilience literature for gifted students with learning disabilities. Roeper Review 2000; 23:91.",
"     </a>",
"    </li>",
"    <li>",
"     Smith C, Strick L. Strategies for Promoting Personal Success. Learning Disabilities: A to Z: A parent's complete guide to learning disabilities from preschool to adulthood, Free Press, New York, NY 1997. p.257.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/37\">",
"      The pediatrician's role in development and implementation of an Individual Education Plan (IEP) and/or an Individual Family Service Plan (IFSP). American Academy of Pediatrics. Committee on Children with Disabilities. Pediatrics 1999; 104:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/38\">",
"      The role of the pediatrician in implementing the Americans with Disabilities Act: subject review. American Academy of Pediatrics Committee on Children with Disabilities. Pediatrics 1996; 98:146.",
"     </a>",
"    </li>",
"    <li>",
"     Johnson J, Duffett A. When it's your own child: A report on special education from the families who use it. Public Agenda Foundation, New York N.Y. 2002. file://www.publicagenda.org/files/pdf/when_its_your_own_child.pdf (Accessed on October 04, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/40\">",
"      Goldman RW. A free appropriate education in the least restrictive enviroment: Promises made, promises broken by the Individuals with Disabilities Education Act. University of Dayton Law Review 1994; 20:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/41\">",
"      Smith TE. Section 504, the ADA, and public schools: What educators need to know. Remedial and Special Education 2001; 22:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/42\">",
"      American Academy of Pediatrics Council on Children With Disabilities, Cartwright JD. Provision of educationally related services for children and adolescents with chronic diseases and disabling conditions. Pediatrics 2007; 119:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/43\">",
"      Bartlett L. Medical services: the disputed related service. J Spec Educ 2000; 33:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/44\">",
"      von Hahn L, Linse C, Hafler J. Hospital assessments of children with learning problems: perspectives from special education administrators and hospital evaluators. Ambul Pediatr 2002; 2:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/45\">",
"      Taras H, Brennan JJ. Students with chronic diseases: nature of school physician support. J Sch Health 2008; 78:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/46\">",
"      Milam-Miller S. The psychiatrist as consultant: working within schools, the courts, and primary care to promote children's mental health. Psychiatr Clin North Am 2009; 32:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/47\">",
"      Walter HJ, Berkovitz IH. Practice parameter for psychiatric consultation to schools. J Am Acad Child Adolesc Psychiatry 2005; 44:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/48\">",
"      Committee on School Health, American Academy of Pediatrics. Guidelines for the administration of medication in school. Committee on School Health. Pediatrics 2003; 112:697.",
"     </a>",
"    </li>",
"    <li>",
"     34 CFR 300.174   Prohibition on mandatory medication. [school personnel cannot require] parents to obtain a prescription for substances identified under schedules I, II, III, IV, or V in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) for a child as a condition of attending school, receiving an evaluation under &sect;&sect;300.300 through 300.311, or receiving services under this part. Authority: 20 U.S.C. 1412(a)(25))",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/50\">",
"      Bateman B. The physician and the world of special education. J Child Neurol 1995; 10 Suppl 1:S114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/51\">",
"      Council for Exceptional Children. Understanding the differences between IDEA and Section 504. Teaching Exceptional Children 2002; 34:16.",
"     </a>",
"    </li>",
"    <li>",
"     34 CFR 300.502 Parent-initiated evaluations. Must be considered by the public agency, if it meets agency criteria, in any decision made with respect to the provision of FAPE to the child. Authority: 20 U.S.C. 1415(b)(1) and (d)(2)(A)",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/53\">",
"      Cooley WC, American Academy of Pediatrics Committee on Children With Disabilities. Providing a primary care medical home for children and youth with cerebral palsy. Pediatrics 2004; 114:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/18/44329/abstract/54\">",
"      Zirkel P, Knapp S. Related services for students with disabilities: What educational consultants need to know. J Educ Psych Consult 1993; 4:137.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15399 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-12BBF70984-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44329=[""].join("\n");
var outline_f43_18_44329=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H629397728\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H546788236\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H546788268\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H629395108\">",
"      EARLY IDENTIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H629395580\">",
"      MEDICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H629395587\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H629395594\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H629395601\">",
"      Informal testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H629395608\">",
"      Ancillary medical testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H546788260\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H546787491\">",
"      Education and counseling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H629397583\">",
"      - Learning disabilities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H288991785\">",
"      - Nonstandard therapies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26836570\">",
"      - Psychosocial management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H629397598\">",
"      - Legal rights",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H973143\">",
"      - Resources",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H629397303\">",
"      Care coordination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H973828\">",
"      Advocacy and support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H546787514\">",
"      Mediator",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H972709\">",
"      Communicating with the school team",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H972939\">",
"      - Useful information",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H972716\">",
"      Written documentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H546787542\">",
"      - Service delivery decisions: PCP's role",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H546787549\">",
"      - Services at school: Educational versus rehabilitative",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H629397728\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/15399\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/15399|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/48/26382\" title=\"table 1\">",
"      LD history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/46/10982\" title=\"table 2A\">",
"      Developmental milestones 4 through 8 yrs A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/26/21924\" title=\"table 2B\">",
"      Developmental milestones 4 through 8 yrs B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/26/12717\" title=\"table 3\">",
"      Learning disability exam",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/36/16972\" title=\"table 4\">",
"      Clues RD early childhood",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/18/25901\" title=\"table 5\">",
"      Clues RD 2nd grade and up",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/31/42492\" title=\"table 6\">",
"      Clues RD young adult",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/20/11597\" title=\"table 7\">",
"      Rehabilitation Act Section 504",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/42/29357\" title=\"table 8\">",
"      Resiliency strategies LD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/4/35917\" title=\"table 9\">",
"      LD resources",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/19/3389\" title=\"table 10\">",
"      Americans with Disabilities Act",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/45/19161?source=related_link\">",
"      Approach to congenital malformations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/5/27737?source=related_link\">",
"      Children with special health care needs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/21/1370?source=related_link\">",
"      Clinical features and evaluation of reading difficulty in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37480?source=related_link\">",
"      Definitions of specific learning disability and laws pertaining to learning disabilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/13/43225?source=related_link\">",
"      Screening tests in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32665?source=related_link\">",
"      Specific learning disabilities in children: Clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37306?source=related_link\">",
"      Specific learning disabilities in children: Educational management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35944?source=related_link\">",
"      Specific learning disabilities in children: Evaluation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_18_44330="Acute ISN Low power";
var content_f43_18_44330=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F66763%7ENEPH%2F64378%7ENEPH%2F78206%7ENEPH%2F55002%7ENEPH%2F67591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F66763%7ENEPH%2F64378%7ENEPH%2F78206%7ENEPH%2F55002%7ENEPH%2F67591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Low power light micrograph of kidney biopsy of a patient with severe acute interstitial nephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 234px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of severe acute interstitial nephritis showing diffuse interstitial inflammatory infiltrate. One normal glomerulus is present at the top of the slide.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    High power light micrograph of kidney biopsy of a patient with acute interstitial nephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power light micrograph of acute interstitial nephritis showing diffuse interstitial infiltrate of inflammatory cells on the right and an uninvolved glomerulus on the left.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph of kidney biopsy of a patient with acute interstitial nephritis showing eosinophils",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph with hematoxylin and eosin stain of acute interstitial nephritis showing diffuse interstitial infiltrate with many red-staining eosinophils. An uninvolved glomerulus is on the left.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    High power light micrograph of kidney biopsy of a patient with acute interstitial nephritis showing diffuse infiltration of mononuclear cells",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power light micrograph of interstitial nephritis showing diffuse interstitial infiltrate of mononuclear cells, many of which are actively invading the tubules leading to disruption of the tubular basement membranes (arrows). A white cell cast is present in the tubule in the upper right corner.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph of kidney biopsy of a patient with granulomatous acute interstitial nephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 255px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph shows granulomatous change in acute interstitial nephritis. The interstitial infiltrate is seen on the left, while the granuloma is on the right. The granuloma consists of both giant cells (arrows) and epithelioid cells with abundant cytoplasm which has an amorphous red appearance. Although these findings are characteristic of sarcoid involvement in the kidney, they can be seen with any cause (drug or infection) of acute interstitial nephritis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44330=[""].join("\n");
var outline_f43_18_44330=null;
var title_f43_18_44331="Risk VTE multiple defects";
var content_f43_18_44331=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F72836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F72836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk of venous thromboembolism associated with use of oral contraceptives, factor V leiden, and/or prothrombin gene mutation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        OC Use*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Factor V Leiden",
"       </td>",
"       <td class=\"subtitle1\">",
"        Factor II G20210A",
"       </td>",
"       <td class=\"subtitle1\">",
"        Odds ratio&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        2.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        3.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        5.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        7.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        10.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        14.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        17.0",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Oral contraceptives; factor II is prothrombin.",
"     <br>",
"      &bull; Crude odds ratio for risk of venous thromboembolism given the combination of risks (-: risk not present; +: risk present).",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Emmerich, J, et al. Thromb Haemost 2001; 86:809.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44331=[""].join("\n");
var outline_f43_18_44331=null;
var title_f43_18_44332="Causes of thrombocytopenia in children";
var content_f43_18_44332=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F61163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F61163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of thrombocytopenia in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Destructive thrombocytopenias",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Immune mediated",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Immune thrombocytopenia (ITP)*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Drug-induced thrombocytopenia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Neonatal immune thrombocytopenias",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Post-transplant thrombocytopenia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Non-immune",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hemolytic-uremic syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Thrombotic thrombocytopenic purpura",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Extracorporeal therapies (eg, cardiopulmonary bypass)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Congenital or acquired heart disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Disseminated intravascular coagulation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Kasabach-Merritt syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypersplenism",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypothermia",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Decreased platelet production",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Nutritional deficiencies",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Acquired bone marrow failure",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Aplastic anemia, myelodysplasic syndromes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Infiltrative bone marrow diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Acute leukemias, metastatic cancers",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Infectious granulomas, storage diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            MYH9-related disorders",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bernard-Soulier syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fanconi anemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Wiskott-Aldrich syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            TAR syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Congenital amegakaryocytic thrombocytopenia (CAMT)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TAR: thrombocytopenia with absent radii.",
"     <br>",
"      * Previously known as idiopathic thrombocytopenic purpura.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44332=[""].join("\n");
var outline_f43_18_44332=null;
var title_f43_18_44333="Contents: Venous disease";
var content_f43_18_44333=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Venous disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Venous disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Chronic venous disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/43/33462\">",
"           Diagnostic evaluation of chronic venous insufficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/41/32410\">",
"           Medical management of lower extremity chronic venous disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/22/43365\">",
"           Pathophysiology of chronic venous disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/5/30809\">",
"           Radiofrequency ablation for the treatment of lower extremity chronic venous disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Phlebitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/37/23127\">",
"           Post-thrombotic (postphlebitic) syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/25/43417\">",
"           Superficial thrombophlebitis of the lower extremity",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Venous thrombosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/30/35305\">",
"           Approach to the diagnosis and therapy of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/26/27050\">",
"           Catheter-induced upper extremity venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/12/33994\">",
"           Diagnosis of suspected deep vein thrombosis of the lower extremity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/48/43786\">",
"           Overview of the causes of venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/52/41802\">",
"           Prevention of venous thromboembolic disease in surgical patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/4/43082\">",
"           Treatment of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-FFBA2D1A26-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f43_18_44333=[""].join("\n");
var outline_f43_18_44333=null;
var title_f43_18_44334="Leak after gastric bypass";
var content_f43_18_44334=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Leak after gastric bypass on upper gastrointestinal series",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Early clinical symptoms of a leak after bariatric surgery are subtle and require clinical vigilance for signs such as low-grade fevers, respiratory compromise, or unexplained tachycardia. A leak (arrow) may be radiographically confirmed by an upper gastrointestinal series (as shown here) or contrast computed tomography (CT). If a leak is suspected clinically, emergent surgical exploration should be performed even if the imaging is negative, given the rapid progression to sepsis in the severely obese patient with comorbidities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Vivian Sanchez, MD and Edward Mun, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44334=[""].join("\n");
var outline_f43_18_44334=null;
var title_f43_18_44335="Sickle cell scanning EM";
var content_f43_18_44335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F77366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F77366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sickle cell by scanning electron micrography (scanning EM)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scanning electron micrograph of a single red blood cell from a patient with sickle cell disease, illustrating the classical \"sickle\" shape.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of RL Nagel, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_18_44335=[""].join("\n");
var outline_f43_18_44335=null;
